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Summary 
Transcription-associated chromatin modifications are recognized now as important 
regulators of gene expression. One of them, the monoubiquitination of lysine 120 
of histone H2B (H2Bub1), is associated with actively transcribed genes. It was 
shown to change the physical properties of the chromatin as well as serve as a 
recognition mark for regulatory chromatin-binding proteins. The misregulation of 
H2Bub1-modifying machinery has been observed to be tightly linked with 
different types of cancer. Many aspects of regulation of H2B monoubiquitination 
remain unknown. 
In the course of this study we presented the data which links H2Bub1 to the 
modifications of RNA polymerase II, proving that H2Bub1 does not depend on 
transcription per se. We also clarified aspects of the regulation of the H2B 
ubiquitinating enzymes. A separate interesting question investigated in this study is 
a rapid and massive loss of H2Bub1 following various cell stresses. Preliminary 
mechanism and signaling pathways which control this process were discovered. 
Together, these studies have uncovered important mechanisms controlling H2Bub1 
and may serve as a basis for developing more potent strategies to combat cancer. 
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1 Introduction 
1.1 RNA polymerase II-mediated transcription overview 
The transcription of most genes is mediated by RNA polymerase II 
(RNAPII). It performs the cycle of transcription in 4 steps: pre-initiation, initiation, 
elongation and 3’-end processing/termination (Fig. 1).  
CTDS2 S5
CTDS2 S5
CTDS2 S5P
CTDS2P S5P
CTDS2P S5P
CTDS2P S5
TFIID
TFIIH
P‐TEFb
I
II
III
IV
 
Figure 1. Regulation of different transcription stages. I. Preinitiation. DNA is 
distorted by the action of TFIID. II. Initiation. TFIIH opens the DNA duplex and 
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phosphorylates serine 5 in RNAPII CTD. The production of abortive transcripts takes place or 
the polymerase is switched to the paused state. III. Elongation. RNAPII is phosphorylated at 
serine 2 by P-TEFb and starts producing full-length transcript. IV. 3’-end processing and 
termination. The transcript is cleaved by an endonuclease activity and the mRNA is normally 
polyadenylated (except for histone mRNAs which have stem loop structure). RNAPII CTD is 
dephosphorylated for the next run and released from DNA. Modified from Lewin's Gene IV. 
 
The pre-initiation step includes the assembly of the Pre-Initiation Complex 
(PIC) on the promoter. It consists of six general transcription factors and the 
RNAPII holoenzyme. TFIID is one of these factors. Its subunits create a distortion 
in the DNA as well as provide proper positioning of the whole complex on the 
promoter.  
The initiation starts when the helicase subunit of TFIIH factor opens the 
DNA duplex creating a so-called transcription bubble. The kinase component of 
TFIIH consisting of Cyclin-Dependent Kinase 7, Cyclin H (CDK7/CCNH) and 
MAT1 phosphorylates serine in the fifth position of RNAPII Carboxyterminal 
Domain (CTD) repeats. The RNAPII starts producing short abortive transcripts. 
For the transition of RNAPII to the next, elongation step, the activity of 
Positive Transcription Elongation Factor b (P-TEFb) is needed. Its components, 
Cyclin-Dependent Kinase 9 and Cyclin T1 (CDK9/CCNT1) phosphorylate and 
inactivate negative elongation factors as well as activate the RNAPII by 
phosphorylating its second serines in CTD repeats.  
At the end of transcription cycle the transcript is terminated and its 3’-end 
is processed into either poly-A tail or stem loop. The RNAPII is dephosphorylated 
to be reused in the next round of transcription (Lee & Young, 2000). 
1.1.1 Role of CTD modifications in the regulation of the transcription 
events 
The large subunit of RNAPII has a carboxy-terminal domain which 
consists of 52 heptapeptide repeats (YSPTSPS) in human (Nonet et al, 1987). 
CDK9 can phosphorylate serine in second position of each repeat. This 
phosphorylation marks the onset of productive elongation of transcription (Kim et 
al, 2002). P-TEFb remains associated with RNAPII as it goes along the gene. 
Subsequently the number of phosphorylated serines in RNA polymerase CTD 
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increases while the enzyme moves toward the 3’-end of the gene (Komarnitsky et 
al, 2000). At the end of the gene the phosphorylation declines and RNAPII gets 
rapidly dephosphorylated to be reused in another cycle of transcription (Cho et al, 
2001).  
Serines in the fifth position of CTD repeats are phosphorylated by the 
TFIIH components CDK7 and Cyclin H during the initiation of transcription 
(Giglia-Mari et al, 2004; Komarnitsky et al, 2000). Unlike p-Ser2 the 
phosphorylation of Ser5 mostly happens near the 5’-end of the gene (Komarnitsky 
et al, 2000). Selective phosphorylations of serines in the positions 2 and 5 were the 
first well-studied elements of a regulatory paradigm later called a “CTD code” 
(Buratowski, 2003). More recently, Ser7 was also shown to be phosphorylated 
(Chapman et al, 2007; Egloff et al, 2007). Tyr1 and Thr4 can also be potential 
phosphorylation sites. Two conserved proline residues (Pro3 and Pro6) can be also 
modified by peptidyl-prolyl isomerases (Shaw, 2007) thus increasing the 
complexity and possible number of combinations of modifications. The variety of 
modification makes the RNAPII CTD a universal docking site for the proteins 
involved in different stages of transcription (Fig. 2). 
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Figure 2. The carboxyl-terminal domain of RNAPII is subjected to various 
posttranslational modifications and serves as a docking site for many transcription-related 
factors. The stages of transcription and co-transcriptioonal processes are listed on the left. 
Yellow circles and red “t”s represent phosphorylations and proline isomerisations, respectively. 
CTD-binding factors are shown as light blue shapes. The proteins listed on the right were all 
shown to directly bind the RNAPII CTD. Taken from (Egloff & Murphy, 2008).  
In brief, the unphosphorylated RNAPII binds TBP and Mediator complex 
in the beginning of transcription cycle (Myers et al, 1998; Usheva et al, 1992).The 
phosphorylation of serine 5 was shown to promote the binding of RNA capping 
enzymes (Phatnani & Greenleaf, 2006) since the cap is required for further mRNA 
survival. As the serine 2 gets phosphorylated and the polymerase goes into the 
elongation stage the phosphorylation of serine 5 declines which can be explained 
by the recruitment of CTD phosphatases to the bi-phosphorylated CTD (Zhang et 
al, 2006). The elongation factor hSUPT6H binds only Ser2-phosphorylated 
polymerase (Yoh et al, 2007).  
Apart from elongation in yeast p-Ser2 has been also shown to play an 
important role in 3’-end processing. The Pcf11, a component of yeast 
cleavage/polyadenylation factor CFIA, is specifically binding the Ser-2 
phosphorylated CDT of RNAPII (Licatalosi et al, 2002).  
1.2 P-TEFb complex 
1.2.1 Regulation of P-TEFb activity 
The P-TEFb complex plays an important role in the regulation of 
transcription and transcription-coupled processes such as mRNA processing and 
chromatin modifications. In this way P-TEFb plays an important role in controlling 
gene transcription under many conditions and can influence such diverse processes 
as cell differentiation and DNA damage repair.  
In its active form the complex consists of a kinase component CDK9 and 
cyclin T1 (CCNT1), and less often T2 or K (Fu et al, 1999; Peng et al, 1998). 
Unlike most other cyclins, CCNT1 is not subjected to a cell cycle-dependent 
regulation and its amount remains constant throughout the cell cycle (Grana & 
Reddy, 1995). However, the activity of P-TEFb complex is tightly regulated.  
CDK9-CCNT1 heterodimers are kept in an inactive state in a complex with 
the HEXIM1 protein and 7SK snRNA (Nguyen et al, 2001; Yang et al, 2001; Yik 
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et al, 2003). About half of P-TEFb complexes can be sequestered in this way 
(Nguyen et al, 2001).  
Like other cyclin-dependent kinases, CDK9 has a conserved threonine 
residue in its T-loop domain. The phosphorylation of this residue changes the 
conformation of the active center to allow for the interaction with a substrate 
(Russo et al, 1996). Thr186 in CDK9 can be dephosphorylated by several 
phosphatases such as PP1α or PP2B (Chen et al, 2008). This dephosphorylation 
happens upon UV-irradiation or hexamethylene bisacetamide (HMBA)-induced 
stress. The activity of these phosphatases is regulated by the Ca2+-calmodulin 
pathway. The dephosphorylated form of CDK9 is released from the HEXIM/7SK 
complex (Chen et al, 2008). Upon release CDK9 can be bound by Brd4 which can 
specifically recognize acetylated histones (Wu & Chiang, 2007) and brings the 
CDK9-CCNT1 complex to the transcription initiation site where it remains 
inactive until the start of productive elongation(Jang et al, 2005; Yang et al, 2005). 
1.2.2 P-TEFb substrates 
One of the first described targets of P-TEFb was RNA polymerase II CTD 
whose function and regulation were described above (Marshall et al, 1996). 
RNAPII is not the only target of CDK9 in the transcription elongation complex. 
Negative elongation factor, NELF, is known to inhibit the transcription elongation 
by binding RNAPII together with another inhibitor, 5,6-dichloro-1-beta-D-
ribofuranosylbenzimidazole (DRB) Sensitivity Inducing Factor DSIF (Wada et al, 
1998a; Yamaguchi et al, 1999). P-TEFb phosphorylates the NELF-E subunit which 
leads to its release from RNAPII binding (Fujinaga et al, 2004). Supressor of Ty 
Homologue-5 (SUPT5H), a component of DSIF, is also phosphorylated by P-TEFb 
(Kim & Sharp, 2001; Wada et al, 1998b). The phosphorylation is localized in 
CTR1, a repeat domain containing several repeats of PSPSPASY sequence 
analogous to RNAPII CTD (Ivanov et al, 2000). In contrast to released NELF, the 
phosphorylated DSIF stays in the complex with RNAPII becoming now a positive 
factor of elongation (Yamada et al, 2006).  
Apart from the regulation of transcription elongation P-TEFb was also 
shown to directly control transcription factor activity. For example, the 
transcription factor MyoD, a key regulator of myoblasts differentiation (Davis et 
al, 1987), is phosphorylated by the CDK9/CCNT2 complex. This phosphorylation 
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increases MyoD activity and promotes the muscular differentiation (Simone et al, 
2002).  
Peroxisome proliferator-activated receptor gamma (PPARγ) is another P-
TEFb-regulated transcription factor. Upon CDK9-mediated phosphorylation 
PPARγ is activated which promotes adipocyte differentiation (Iankova et al, 2006). 
   
 
1.3 H2B ubiquitination. 
1.3.1 Overview of chromatin structure 
Chromatin is a complex of DNA, histones and other proteins that form 
chromosome. The basic unit of the chromatin is the nucleosome. The typical 
nucleosome is a heterooctamer consisting of two histone H3-H4 dimers which 
form a stable tetramer as well as two flanking histones H2A-H2B dimers. Standard 
nucleosome consisting of canonical histones is wrapped by 147 base pairs of DNA 
(Davey et al, 2002; Luger et al, 1997).  
While the core domains of histones perform solely structural function, the 
N- and C-terminal tails are exposed outside the nucleosome and often subjected to 
a wide range of posttranslational modifications including acetylation and 
ubiquitination of lysines, methylation of lysines and arginines, and 
phosphorylation of serines and threonines (Turner, 2007) (Fig. 3). 
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Figure 3. Variety of histone modifications. The core parts of histones are represented 
as colored ovals. Tails are shown as sequences of aminoacids. Modifications: me-methylation, 
ph-phosphorylation, ac-acetylation, ub1-monoubiquitination. Taken from: (Bhaumik et al, 2007).  
  
This wide variety of modifications and their relatively uniform distribution 
in the same regions of many genes (Fig. 4) gave rise to the concept of histone code 
(Strahl & Allis, 2000). This hypothesis suggests a combinatorial effect of histones 
modifications on the recruitment of chromatin-interacting factors with specific 
biological functions. In general, there are marks mostly associated with inactive 
chromatin, such as hypoacetylation, H3K9me3 and H3K27me3 while the 
hyperacetylation, H3K4me3 and H3K36me3 are found mostly on transcribed 
genes (Ruthenburg et al, 2007).  
The precise location of histone modifications in different regions of a gene 
is achieved by close integration of chromatin-modifying enzymes with the 
transcription apparatus (Fig. 4). A good example of such regulation is 
trimethylation of histone H3K4. It is performed by Set1p methyl transferase which 
is recruited to the serine 5-phosphorylated RNAPII at the 5’-end of a gene (Liu et 
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al, 2005; Ng et al, 2003; Santos-Rosa et al, 2002). Similarly, H3K36me3 is 
controlled by Set2p which is associated with a dually Ser2/Ser5-phosphorylated 
elongating RNAPII and is mostly detected in the middle and 3’-end regions of 
active genes (Carrozza et al, 2005; Keogh et al, 2005).  
 
Figure 4. Chromatin map of an active human gene. Modified from (Rando & Chang, 
2009). 
 Apart from modifications of canonical histones the epigenetic background 
can be altered by the incorporation of histone variants. Histones H2A and H3 have 
physiologically important variants while H2B and H4 are mostly invariant (Malik 
& Henikoff, 2003).  
The H2A.Z variant in mammals is predominantly localized in the enhancer 
elements, insulator regions and around the transcription a start site (Barski et al, 
2007; Schones et al, 2008) 
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H2A.Bbd lacks 13 of 14 acetylatable lysines, the ubiquitinatable C-terminal 
tail and and the acidic region which contacts H4 (Doyen et al, 2006). As a result 
the H2A.Bbd-containing nucleosomes bind only 118 DNA residues and are 
significantly less stable (Bao et al, 2004).   
In contrast macroH2A contains large non-histone c-terminal tail and is 
much bigger than canonical H2A (Pehrson & Fried, 1992). Due to the increased 
stability of macroH2A-containing nucleosomes they are mostly found in 
transcriptionally inactive regions such as the inactivated X-chromosome and 
methylated CpG islands (Choo et al, 2006; Costanzi & Pehrson, 1998). 
The highly transcribed regions of chromatin are also marked by the the 
H3.3 variant. Being only 5 amino acids different from canonical H3 it nevertheless 
makes nucleosomes extremely unstable (Jin & Felsenfeld, 2007). In contrast, H3.1 
variant is also found in significant proportion in silenced chromatin regions (Hake 
& Allis, 2006). 
The H2A.X variant constitutes about 10% of total H2A in human cells. It is 
phosphorylated in the region of double strand DNA break by DNA damage 
response kinases like ATM, ATR and DNA-PK (Burma et al, 2001; Stiff et al, 
2004)4-6. The size of phosphorylated region around the break can reach a 
megabase (Rogakou et al, 1999). The loss of H2A.X causes impaired formation of 
DNA damage repair loci with reduced accumulation of basic repair factors like 
MDC1, BRCA1 and 53BP1 while the initial recruitment of this factors still takes 
place (Celeste et al, 2003; Paull et al, 2000; Ward et al, 2003). 
1.3.2 H2B monoubiquitination 
Monoubiquitination of Lysine in the C-terminal tail of histone H2B is 
conserved from yeast (K123) to human (K120) (Robzyk et al, 2000; Thorne et al, 
1987). Like all other ubiquitination reactions this requires the activity of E1, E2 
and E3 ubiquitinating enzymes which subsequently transfer the activated ubiquitin 
molecule to the target protein (Pickart, 2001). The E2 ubiquitin conjugating 
enzyme for H2B in yeast is called Rad6 (Robzyk et al, 2000). In human this 
function is assigned to the Rad6 homolog the UBE2A protein (Kim et al, 2009). 
Bre1 serves as an E3 ubiquitin ligase of H2B in the yeast Saccharomyces 
cereviseae (Wood et al, 2003). In human Bre1 has two homologs, Bre1A and 
Bre1B, also refered to as RNF20 and RNF40. A heterodimeric complex of the E3 
Introduction 
 
10 
 
ring-finger ubiquitin ligases RNF20 and RNF40 is responsible for the final step of 
ubiquitin transfer to the H2B, however, in vitro only RNF20 enzymatic activity is 
needed for the reaction (Kim et al, 2005; Zhu et al, 2005).  
Since monoubiquitination of H2B does not lead to protein degradation the 
ubiquitin moiety has to be removed in order to suppress the signaling when 
necessary. In yeast two ubiquitin proteases were described, Ubp8 and Ubp10. 
Ubp8 is a component of the Spt-Ada-Gcn5-acetyltransferase (SAGA) complex 
(Daniel et al, 2004). In humans the ortholog of Ubp8, USP22 was found (Zhang et 
al, 2008). As in yeast, USP22 requires the interaction with other SAGA complex 
subunits CG13379 and ATXN7L3 for its deubiquitination activity (Henry et al, 
2003; Zhao et al, 2008). Interestingly, unlike yeast, in which H2A is not 
ubiquitinated, USP22 deubiquitinated not only H2B, but also H2A (Zhao et al, 
2008) 
Unlike Upb8 the ubiquitin protease Ubp10 is not associated with the active 
fraction of the genome. Instead it interacts with the silencing protein Sir4 and plays 
a role in silencing telomeric regions as well as rRNA genes (Emre et al, 2005). No 
human orthologs of Ubp10 were described so far. 
1.3.3 Function of H2B ubiquitination 
The attachment of a bulky ubiquitin to H2B histone was shown to 
significantly modify the properties of chromatin in vitro. The compaction of the 
chromatin into 30 nm fiber was severely impared when ubiquitinated H2B was 
incorporated into nucleosomes. Besides, such chromatin was shown to be more 
available for the Dot1L methyltransferase (Fig. 5) (Fierz et al, 2011).  
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Figure 5. H2B ubiquitination in the context of 30-nm fiber. Tetranucleosome unit 
extracted from the fiber and rotated by 38.1o. Red arrows indicate the sites of ubiquitin (pink) 
attachment. Modified from (Fierz et al, 2011)  
In yeast, monoubiquitinated H2B has been generally associated with the 
promoters and coding regions of actively transcribed genes (Henry et al, 2003; Kao 
et al, 2004; Xiao et al, 2005). Yeast strains which have a K123R mutation in H2B 
demonstrated strong transcriptional defects. H2B ubiquitination was shown to be 
important for the recruitment of COMPASS methyltransferase complex to the 
chromatin. This way of epigenetic regulation was called trans-tail histone 
modifications (Fischle et al, 2003). Di- and trimethylation of lysines 4 and 79 on 
histone H3 were significantly impaired in strains lacking H2Bub1 (Lee et al, 
2007). The absence of H2Bub1 caused the overall reduction of nucleosome 
occupancy in the transcribed regions of the genes. The initiation of transcription 
from intragenic cryptic transcription sites was also detected. This way be explained 
by the fact that H2Bub1 was found to be in a close functional interaction with the 
FACT (Facilitates Active Chromatin Transcription) complex (Fleming et al, 2008; 
Pavri et al, 2006). FACT, being a H2A/H2B chaperone is involved in the 
disassembly and reassembly of nucleosomes during the transcription (Fig. 6) 
(Belotserkovskaya et al, 2003).  
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Figure 6. Dynamics and role of H2B monoubiquitination in transcription 
elongation. Modified from (Laribee et al, 2007) 
Quite recently the mechanistic explanation was given for H2Bub1-
mediated chromatin alterations. It was shown that despite disrupting the 30-nm 
fiber structure H2Bub1 strongly increases the stability of individual nucleosomes. 
This, in fact, stabilized the binding of the FACT subunit Spt16 to the nucleosome 
in front of RNAPII and insures the proper chromatin reconstitution in the wake of 
RNA polymerase (Chandrasekharan et al, 2009).  
In human cells the role of H2Bub1 in supporting the level of histone 
methylation was also shown. The overexpression of RNF20 led to the 
accumulation of H3K4me1, H3K4me3 and H3K79me3 (Zhu et al, 2005). The 
depletion of RNF20 and RNF40 with siRNA resulted in a significant decrease of 
the same histone methylations. The presence of RNF20/40 was shown to be 
essential for the expression of genes from HoxA cluster. Most of the genes were 
upregulated and downregulated by the overexpression and siRNA-mediated 
depletion of H2B E3 ubiquitin ligases, respectively. Moreover, chromatin 
immunoprecipitation showed that HoxA genes, which where regulated by H2Bub1, 
had significant changes of histone H3 methylations upon RNF20/40 
overexpression or knockdown. Altogether that provided first robust model of gene 
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expression regulation by H2Bub1 in human cells. Supporting evidence for a 
positive role of H2Bub1 in transcription came from further studies in which the 
retinoic acid-induced transcription of retinoic acid receptor-alpha gene was shown 
to depend upon RNF20 and 40 in vivo and H2Bub1 in vitro (Pavri et al, 2006).  
One of the components of H2B ubiquitinating complex, RNF20 has been 
found to be a putative tumor suppressor. Surprisingly, it has a repressive influence 
on the induction of EGF-responsive genes (Shema et al, 2008). Moreover, its 
depletion promotes cell migration and its promoter is hypermethylated in many 
tumors. 
Not only the expression of genes but also the processing of transcripts is 
regulated by H2Bub1 in human. The 3’-ends of the replication dependent histone 
genes are normally processed into stem loop structure by stem loop-binding protein 
SLBP and U7 small nuclear ribonuclear protein (snRNP) (Marzluff et al, 2008). 
Recently it has been shown that upon the depletion of RNF20/40 RNAPII with 
higher probability skips the site of 3’-end processing and synthesizes a longer 
polyadenylated transcript (Pirngruber et al, 2009b). 
In the sites of DNA brakes the chromatin undergoes different 
modifications. Recent reports show an accumulation of H2Bub1 on the damaged 
chromatin as well as the interaction of H2B ubiquitinating enzymes with DNA 
repair machinery (Moyal et al, 2011; Nakamura et al, 2011). In accordance with 
the above mentioned in vitro data H2Bub1 accumulation might play an important 
role in decompacting the chromatin for the double-stranded DNA break repair. 
 
1.4 Rad6 
1.4.1 Rad6 in yeast 
Rad6 was one of the first yeast proteins identified as a regulator of H2B 
ubiquitination. This E2 ubiquitin conjugating enzyme was shown to ubiquitinate 
H2B in vivo and in vitro (Robzyk et al, 2000). Later it was demonstrated that the in 
vivo activity of Rad6 is not detected if Bre1, an E3 RING-finger ubiquitin ligase 
was not present (Wood et al, 2003).  
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Figure 7. Multiple functions of Rad6 in yeast. Taken from (Game & Chernikova, 
2009) 
 
Like most E2 enzymes, Rad6 is involved in the ubiquitination of several 
substrates (Fig. 7). Proliferating Cell Nuclear Antigen (PCNA) has been shown to 
be ubiquitinated at lysine 164 by Rad6 in a complex with the E3 ubiquitin ligase 
Rad18. In a complex with another E3 ubiquitin ligase, Rad5, Rad6 can convert the 
monoubiquitination of PCNA into a K63-linked poliubiquitin chain (Hoege et al, 
2002). This ubiquitination mark promotes the interaction of DNA polymerase eta 
with the DNA clamp PCNA to activate the translesion DNA synthesis pathway in 
both yeast and human (Haracska et al, 2001; Haracska et al, 2004; Kannouche et 
al, 2004). The N-end rule pathway of protein degradation also makes use of Rad6 
where it serves as an E2 enzyme for E3 ubiquitin ligase Ubr1 (Dohmen et al, 1991) 
1.4.2 UBE2A (hRAD6) 
The closest homolog of yeast Rad6 in human are called UBE2A (Fig. 8) 
and UBE2B. However, UBE2A appears to be the predominantly expressed form. 
In resemblance to its yeast homolog it is involved in the ubiquitination of histone 
H2B in a complex with E3 ubiquitin ligases RNF20/RNF40 (Kim et al, 2009). The 
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ubiquitination of human PCNA is also mediated by UBE2A in association with E3 
ligase hRAD18 (Watanabe et al, 2004). 
 
 
Figure 8. Alignment of amino acid sequences of yeast Rad6 and human UBE2A. 
Conserved phosphorylated serine residue is marked in red. (Done by EMBOSS alignment tool.) 
 
 1.4.3 Regulation of Rad6 activity 
The Bur1/Bur2 complex is essential for yeast growth and consists of the 
cdc28-related kinase Bur1 and cyclin T family member Bur2 (Yao et al, 2000). It 
has been shown to phosphorylate Rad6 at serine 120 in yeast and this 
phosphorylation is necessary for the ability of Rad6 to ubiquitinate H2B (Wood et 
al, 2005). 
In human cells UBE2A can also be phosphorylated at conserved serine 120 
by CDKs 1 and 2 (Sarcevic et al, 2002). In vivo the phosphorylation of UBE2A 
increases during the G2/M transition. The mutation of serine 120 into alanine 
abolishes UBE2A activity  
1.5 Loss of H2B ubiquitination 
H2Bub1 is a dynamic chromatin modification. A severe decrease of H2B 
ubiquitination was shown upon treating cells with different stress-inducing factors 
such as proteosome inhibitors, heat shock, sodium arsenite, cadmium chloride, 
doxorubicin, Actinomycin D or DRB (Davie & Murphy, 1990; Mimnaugh et al, 
1997; Minsky et al, 2008). That suggests the existence of a universal mechanism of 
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chromatin modification in response to different stresses. As an explanation of the 
observed effect the depletion of free ubiquitin or the inhibition of transcription 
were proposed (Davie & Murphy, 1994). 
1.5.1 Nucleoli and stress conditions 
1.5.1.1 Nucleoli overview 
Nucleoli are subnuclear organelles where the production of small and large 
subunits of ribosomes takes place. Therefore their function must be tightly 
regulated in different growth conditions (Lempiainen & Shore, 2009). Three 
distinct processes occur in the nucleoli: pre-rRNA transcription, processing, and 
ribosomal RNP assembly. Accordingly, three compartments are distinguished in 
nucleolar microstructure. The fibrillar center (FC) hosts the transcription, dense 
fibrillar component (DFC) is a place of rRNA processing while the assembly of 
ribosomal subunits happens in the granular component (GC) (Boisvert et al, 2007) 
.  
1.5.1.2 Nucleolar reaction to stress 
In stress conditions the structure of nucleoli undergoes different changes. 
One of them is called nucleolar segregation and is caused by UV irradiation, 
topoisomerase inhibitors or actinomycin D. During this process the FC and GC are 
condensed and separated while the nucleolar cap is formed from nucleolar and 
nuclear proteins around the nucleolar remnant (Al-Baker et al, 2005; Shav-Tal et 
al, 2005).  
The nucleolar proteome contains about 4500 different proteins while only 
30% of them are directly involved in ribosomal biosynthesis (Ahmad et al, 2009). 
The rest are involved in DNA replication and repair, apoptosis control, RNP 
biogenesis and cell cycle regulation. The studies involving quantitative mass 
spectrometry and fluorescence microscopy of more than 1000 nucleolar proteins 
revealed a massive translocation of factors involved in nucleolar stress, DNA 
damage pathway and oxidative stress response upon treatment with the 
topoisomerase I inhibitor camptothecin. This translocation has been shown to be 
quite rapid so that some components changed their localization already in two min 
after adding the drug (Cohen et al, 2008). 
A typical mechanism of cell cycle regulation by nucleolar signaling 
involves the regulation of p53 level. In normally growing cells p53 protein levels 
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are kept low due to its constant ubiquitination by the E3 ubiquitin ligase HDM2 
which marks p53 for proteosomal degradation (Kruse & Gu, 2009). The activity of 
HDM2 can be inhibited by p14ARF, a protein with nucleolar localization (Sherr, 
2001). The ARF protein is itself very unstable. It is also ubiquitinated by the E3 
ligase UlF and subsequently degraded. Another important nucleolar component, 
nucleophosmin (NPM) has been shown to abrogate ARF degradation thus 
inhibiting HDM2 activity and stabilizing p53 to block the progression of cell cycle 
progression (Chen et al, 2010). 
1.5.2 Cajal bodies and nucleoli 
Chemoterapeutics
snoRNAs/snRNAs
Transcription
inhibitors
Ultraviolet irradiation Osmotic stress
A
B
Cytoplasm
Nucleus
Nucleolus
Cajal body
snoRNAs
 
Figure 9. Nucleoli and Cajal bodies. A. Functional interaction between CBs and 
nucleoli. SnRNAs are transcribed from their locus (yellow) adjacent to CBs (red) (Frey & 
Matera, 2001) and then are transported to the cytoplasm (grey) for splicing. After re-import to 
the nucleus snRNAs undergo final maturation in CBs and migrate to the nucleolus (green) as a 
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part of snRNP complexes which are involved in rRNA processing. B. Upon different stress 
conditions nucleolar components (nucleophosmin, green) are released to the nucleoplasm 
whereas CB components (p80-coilin, red) migrate to the periphery of the nucleolus. 
Cajal bodies (CBs) are distinct nuclear structures which function in the 
processing of different types of RNAs such as snRNAs, snoRNAs and histone 
mRNAs (Kiss et al, 2006; Matera et al, 2007; Nizami et al, 2010). One of the main 
components of CBs, p80-coilin is used as a CB marker and plays an important role 
in snRNP biogenesis and splicing (Cioce & Lamond, 2005; Strzelecka et al, 2010).  
CBs are linked to nucleoli both physically and functionally. In the nuclei of 
neurons these organelles are closely associated (Lafarga et al, 1986). The snoRNPs 
which undergo maturation in CBs are later transported to the nucleoli to serve for 
the rRNAs processing (Fig. 9A). Moreover, a constant shuttling of proteins like 
Nopp140 between the nucleoli and CB makes the connection between these 
compartments even more obvious. Nopp140 is a snoRNP chaperone and it 
probably acts as a transporter of snoRNPs to the nucleoli (Isaac et al, 1998). In 
micronucleated cells coilin was shown to be co-localized with nucleolar 
components such as fibrillarin, NOR-90 and RNA polymerase I. The functional 
role of such a protein localization shift remains unclear (Silva et al, 2004) . 
1.5.3 Cajal bodies under stress 
CBs undergo different transformations upon the exposure of cells to 
different stress conditions. Starvation decreases the number of CBs (Andrade et al, 
1993), UV-C irradiation, osmotic stress and heat shock cause redistribution of 
coilin to nucleoplasmic microfoci as well as formation of so called nucleolar caps 
which also form upon actinomycin D treatment (Cioce et al, 2006; Handwerger et 
al, 2002; Shav-Tal et al, 2005). In HeLa cells, the overexpression of a 
phosphorylation site-mimicking mutant coilin (S202D) resulted in nucleolar 
localization of this protein together with splicing snRNAs, suggesting the 
importance of S202 phosphorylation for the localization of CB components (Lyon 
et al, 1997). 
1.5.4 Nucleoli and JNK signaling 
C-Jun N-terminal kinase JNK belongs to the stress-activated protein kinase 
(SAPK) family and plays an important role in the cellular reaction to stress factors, 
regulating the choice between survival and apoptosis (Chen et al, 1996). The 
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activity of JNK is increased upon exposure to UV-irradiation, alkylating agents, 
actinomycin D, hyperosmotic shock and oxidative damage (Martindale & 
Holbrook, 2002; Song & Lee, 2007; Yoon & Kim, 2004). JNK activity is regulated 
by phosphorylation of threonine and tyrosine residues in the T*PY* motif by 
SEK1/MKK4 (Derijard et al, 1995). JNK inhibits the function of nucleoli by 
phosphorylating the key rRNA transcription factor TIF-IA (Bodem et al, 2000; 
Mayer et al, 2005). The inhibition of RNA polymerase I activity itself results in the 
development of the so-called “nucleolar stress response” which can cause p53 
stabilization by ARF, L5 and L11 (Dai & Lu, 2004; Lohrum et al, 2003) release as 
described previously.  
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2. Materials 
2.1 Equipment 
Agarose gel chamber Harnischmacher Labortechnik, Kassel 
Balance Sartorius AG, Göttingen 
Bandelin Sonoplus Sonicator Bandelin electr. GmbH & Co. KG, 
Berlin 
Biological Safety Cabinet “Hera 
Safe” 
Thermo Fisher Scientific, Waltham, 
USA 
Bioruptor Diagenode SA, Liège, Belgium 
Centrifuge (Megafuge 1.OR)  Thermo Fisher Scientific, Waltham, 
USA 
Centrifuge 4 °C (5417R) Eppendorf AG, Hamburg 
C1000TM Thermal Cycler  Bio-Rad Laboratories GmbH, 
München 
CFX96TM Optical Reaction 
Module 
Bio-Rad Laboratories GmbH, 
München 
Confocal microscope LSM510 
META 
Carl Zeiss GmbH  
Counting chamber (Neubauer) Brand GmbH & Co. KG, Wertheim 
5100 Cryo 1 °C Freezing Container Thermo Fisher Scientific 
Electrophoresis & Electrotransfer 
Unit 
GE Healthcare Europe GmbH, 
München 
Freezer -20 °C Liebherr GmbH, Biberach 
Freezer -80 °C “Hera freeze” Thermo Fisher Scientific, Waltham, 
USA 
Gel Imager “Gel iX imager”  Intas Science Imaging GmbH, 
Göttingen 
Incubator (bacteria) Memmert GmbH & Co. KG, 
Schwabach 
Incubator (bacteria culture) Infors AG, Bottmingen 
Incubator (cell culture) “Hera cell 
150“ 
Thermo Fisher Scientific, Waltham, 
USA 
Inverse Microscope “Axiovert 40 
CFL” 
Carl Zeiss MicroImaging GmbH, 
Göttingen 
Magnet stirrer “MR3001” Heidolph GmbH & Co. KG, 
Schwabach 
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Microscope “Axiovert 40 C“ Carl Zeiss MicroImaging GmbH, 
Göttingen 
Microwave Clatronic International GmbH, 
Kempen 
Nano Drop® ND-1000 
Spectrophotometer 
Peqlab Biotechnology GmbH, 
Erlangen 
Pestle Sartorius AG, Göttingen 
pH meter inoLab® WTW GmbH, Weilheim 
Phosphoimager TYPHOON 9400 Amersham Biosciences 
Pipette Aid® portable XP Drummond Scientific Co., Broomall, 
USA 
Pipettes “Research” Series Eppendorf AG, Hamburg 
Power supply “Power Pack P25T” Biometra GmbH, Göttingen 
Refrigerator Liebherr GmbH, Biberach 
Repeat Pipette  Eppendorf AG, Hamburg 
Scanner (CanoScan 8600F) Canon GmbH, Krefeld 
Shaker “Rocky” Schütt Labortechnik GmbH, Göttingen 
Table centrifuge (GMC-060)  LMS Co., Ltd., Tokyo, Japan 
Test tube rotator Schütt Labortechnik GmbH, Göttingen 
Ultrapure Water System “Aquintus” membraPure GmbH, Bodenheim 
Vacuum pump Integra Bioscienc. AG, Zizers, 
Switzerland 
Vortex mixer Scientific Industries, Inc., Bohemia, 
USA 
Water bath “TW 20” JULABO Labortechnik GmbH, 
Seelbach 
X-Ray Cassettes Rego X-ray GmbH, Augsburg 
 
2.2 Consumables 
Cellstar 6- and 12-well cell culture 
plate 
Greiner Bio-One GmbH, 
Frickenhausen 
Cellstar PP-tube 15 and 50 ml Greiner Bio-One GmbH, 
Frickenhausen 
Cellstar tissue culture dish 100×20 mm Greiner Bio-One GmbH, 
Frickenhausen 
Cellstar tissue culture dish 145×20 mm Greiner Bio-One GmbH, 
Frickenhausen 
Cell scraper (16 cm) Sarstedt AG & Co., Nümbrecht 
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Cryo TubeTM Vial (1.8 ml) Thermo Fisher Scientific, Waltham, 
USA 
Falcon® assay plate, 96 well VWR Int., LLC, West Chester, 
USA 
Gel blotting paper (Whatman paper) Sartorius AG, Göttingen 
Glass coverslips (18 mm) Gebr. Rettberg GmbH, Göttingen 
HybondTM-PVDF Transfer Membrane GE Healthcare Europe GmbH, 
München 
Microtube 1.5 ml Sarstedt AG & Co., Nümbrecht 
Microtube 1.5 ml, conical VWR International GmbH, 
Darmstadt 
Microtube 2 ml Sarstedt AG & Co., Nümbrecht 
96 Multiply® PCR plate white Sarstedt AG & Co., Nümbrecht 
96-well Multiplate® PCR plate white 
(low) 
Bio-Rad Laboratories GmbH, 
München 
Parafilm® “M” Pechiney Plastic Packaging, 
Chicago, USA 
Petri dish 92×16 mm Sarstedt AG & Co., Nümbrecht 
Pipette tips Greiner Bio-One GmbH, 
Frickenhausen 
Pipette filter tips Sarstedt AG & Co., Nümbrecht 
Protan® Nitrocellulose transfer 
membrane 
Whatman GmbH, Dassel 
X-ray films “Super RX” Fujifilm Corp., Tokyo, Japan 
 
2.3 Chemicals 
2.3.1 General chemicals 
Acetic acid Carl Roth GmbH & Co. KG, Karlsruhe 
Adefodur WB developing 
concentrate 
Adefo-Chemie GmbH, Dietzenbach 
Adefodur WB fixing concentrate Adefo-Chemie GmbH, Dietzenbach 
Adenosin triphosphate (ATP) Fermentas GmbH, St. Leon-Rot 
Agarose Carl Roth GmbH & Co. KG, Karlsruhe 
Albumin Fraction V (BSA) Carl Roth GmbH & Co. KG, Karlsruhe 
Ammonium persulfate (APS) Carl Roth GmbH & Co. KG, Karlsruhe 
Ammonium sulfate (NH4)2SO4 Carl Roth GmbH & Co. KG, Karlsruhe 
Aprotinin Carl Roth GmbH & Co. KG, Karlsruhe 
Bromophenol blue Sigma-Aldrich Co., St. Louis, USA 
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Calcium Chloride (CaCl) Carl Roth GmbH & Co. KG, Karlsruhe 
Chelex Bio-Rad Laboratories GmbH, München 
Chloramphenicol Serva Electrophoresis GmbH, Heidelberg 
Chloroform Carl Roth GmbH & Co. KG, Karlsruhe 
Diethylpyrocarbonate (DEPC) Carl Roth GmbH & Co. KG, Karlsruhe 
Dimethyl sulfoxide (DMSO) AppliChem GmbH, Darmstadt 
Dithiothreitol (DTT) Carl Roth GmbH & Co. KG, Karlsruhe 
DMEM GIBCO®, Invitrogen GmbH, Darmstadt 
dNTPs Promega GmbH, Mannheim 
Doxorubicin Enzo Life Sciences GmbH, Lörrach 
Ethanol absolute Th. Geyer GmbH & Co. KG, Renningen 
Ethidium bromide Carl Roth GmbH & Co. KG, Karlsruhe 
Ethylenediaminetetraacetic acid 
(EDTA) 
Carl Roth GmbH & Co. KG, Karlsruhe 
Fetal Bovine Serum (FBS) Thermo Scientific HyClone, Logan, USA 
Formaldehyde Sigma-Aldrich Co., St. Louis, USA 
Glycerol Carl Roth GmbH & Co. KG, Karlsruhe 
ß-Glycerolphosphate (BGP) Sigma-Aldrich Co., St. Louis, USA 
Glycine Carl Roth GmbH & Co. KG, Karlsruhe 
GlycoBlue Applied Biosystems/Ambion, Austin, 
USA 
Hydrochloric acid (HCl) Carl Roth GmbH & Co. KG, Karlsruhe 
Isopropanol Carl Roth GmbH & Co. KG, Karlsruhe 
Kanamycin AppliChem GmbH, Darmstadt 
Leupeptin Carl Roth GmbH & Co. KG, Karlsruhe 
Magnesium chloride (MgCl2) Carl Roth GmbH & Co. KG, Karlsruhe 
Methanol M. Baker B.V., Deventer, Netherlands 
MG-132 Biomol GmbH, Hamburg 
Monopotassium phosphate 
(KH2PO4) 
Carl Roth GmbH & Co. KG, Karlsruhe 
N-ethylmaleimide (NEM) Sigma-Aldrich Co., St. Louis, USA 
NonidetTM P40 (NP-40) Sigma-Aldrich Co., St. Louis, USA 
Opti-MEM GIBCO®, Invitrogen GmbH, Darmstadt 
PBS tablets GIBCO®, Invitrogen GmbH, Darmstadt 
Pefabloc SC Protease Inhibitor Carl Roth GmbH & Co. KG, Karlsruhe 
Penicillin-Streptomycin solution Sigma-Aldrich Co., St. Louis, USA 
Peptone Carl Roth GmbH & Co. KG, Karlsruhe 
Potassium acetate (KOAc) Carl Roth GmbH & Co. KG, Karlsruhe 
Potassium chloride (KCl) AppliChem GmbH, Darmstadt 
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Potassium dihydrogen phosphate 
(KH2PO4) 
Carl Roth GmbH & Co. KG, Karlsruhe 
Propidium iodide solution Sigma-Aldrich Co., St. Louis, USA 
Protein A SepharoseTM CL-4B GE Healthcare, Uppsala, Sweden 
RNase inhibitor New England Biolabs, Frankfurt am 
Main 
RNAiMAX Invitrogen GmbH, Karlsruhe 
Roti®-Phenol QIAGEN Sciences 
Rotiphorese® Gel 30 Carl Roth GmbH & Co. KG, Karlsruhe 
Rotipuran® Chloroform Carl Roth GmbH & Co. KG, Karlsruhe 
Rotipuran® Isoamylalcohol Carl Roth GmbH & Co. KG, Karlsruhe 
Salmon sperm DNA Stratagene, La Jolla, USA 
SepharoseTM CL-4B GE Healthcare, Uppsala, Sweden 
Skim milk powder Carl Roth GmbH & Co. KG, Karlsruhe 
Sodium acetate Carl Roth GmbH & Co. KG, Karlsruhe 
Sodium chloride (NaCl) Carl Roth GmbH & Co. KG, Karlsruhe 
Sodium deoxycholate AppliChem GmbH, Darmstadt 
Sodium dodecylsulfate (SDS) Carl Roth GmbH & Co. KG, Karlsruhe 
di-Sodium hydrogen phosphate 
dihydrate 
Carl Roth GmbH & Co. KG, Karlsruhe 
Sodium hydroxide (NaOH) Carl Roth GmbH & Co. KG, Karlsruhe 
Sodium pyruvate (Na-Pyr) GIBCO®, Invitrogen GmbH, Darmstadt 
SYBR Green Roche Diagnostics GmbH, Mannheim 
TEMED Carl Roth GmbH & Co. KG, Karlsruhe 
α,α-Trehalose Dihydrate USB Corporation, Cleveland, USA 
Tris Carl Roth GmbH & Co. KG, Karlsruhe 
Triton X-100 AppliChem GmbH, Darmstadt 
TRIzol® Reagent Invitrogen GmbH, Karlsruhe 
Trypsin-EDTA (0.05%) GIBCO®, Invitrogen GmbH, Darmstadt 
Tween-20 AppliChem GmbH, Darmstadt 
Yeast Extract USB Corporation, Cleveland, USA 
 
2.3.2 Inhibitors 
Actinomycin D Sigma-Aldrich 
alpha-amanitin Sigma-Aldrich 
Caffeine Sigma-Aldrich 
Camptothecin Sigma-Aldrich 
Cholerae toxin EMD Chemicals 
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Cisplatin Zytostatika 
Cyclosporine A Sigma-Aldrich 
Doxorubicin Enzo Life Sciences 
DRB Sigma-Aldrich 
Etoposide Sigma-Aldrich 
Hydroxyurea Sigma-Aldrich 
Iodacetamide Sigma-Aldrich 
KM05283 Thermo Fisher Sc. Int. 
MG132 Sigma-Aldrich 
NAC Affymetrix 
NiCl2 Sigma-Aldrich 
Nutlin-3A Sigma-Aldrich 
Ocadaic acid Tocris 
Olaparib Santa Cruz 
Rapamycin Calbiochem 
SB 203580 Biomol 
Sorbitol USB Corporation 
SP600125 Sigma-Aldrich 
Trolox Sigma-Aldrich 
 
2.4 Kits and reagents 
LipofectamineTM 2000 Invitrogen GmbH, Karlsruhe 
LipofectamineTM RNAiMAX Invitrogen GmbH, Karlsruhe 
PureYieldTM Plasmid Midiprep Promega GmbH, Mannheim 
QIAprep® Spin Miniprep Kit Qiagen GmbH, Hilden 
SuperSignal® West Dura Thermo Fisher Scientific, Waltham, 
USA 
SuperSignal® West Femto 
Maximum 
Thermo Fisher Scientific, Waltham, 
USA 
 
2.5 Nucleic acids 
2.5.1 Plasmids 
Name Source 
pCDNA3.1hygro(+) Invitrogen 
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pCDNA3.1hygro(+)-HA-hCDK9 this study 
pGEX-6P-1 GE Healthcare 
pGEX-6P-1-hUBE2AA-WT this study 
pGEX-6P-1-hUBE2AA-S120A this study 
pCS2 (Knockaert et al, 2006) 
pCS2-Flag-SCP1 (Knockaert et al, 2006) 
pCS2-Flag-SCP2 (Knockaert et al, 2006) 
pCS2-Flag-SCP3 (Knockaert et al, 2006) 
pSTC-TK-WTRpb1-EGFP D. Eick 
pSTC-TK-Rpb1-dCTD-EGFP D. Eick 
pSTC-TK-Rpb1-1-3+S2A48+52 D. Eick 
pSTC-TK-Rpb1-1-3+S5A48+52 D. Eick 
pHA-JNK1 R. Janknecht 
pHA-MEKKc R. Janknecht 
 
2.5.2 Oligonucleotides 
2.5.2.1 siRNAs 
Gene Cat. Num Sense sequence Source 
CDK9 S2834 UGA GAU UUG UCG AAC CAA Att Ambion 
CCNT S2541 CGACCCAGACAAUAGACUAtt Ambion 
NCL SI00300923 GCUAUGGAGACUACACCAGtt Qiagen 
NPM SI00300979 GAAUUGCUUCCGGAUGACUtt Qiagen 
UBE2A S14567 UUCAUAUUCCCGUUUGUUCtc Ambion 
RNF20 S32088 GGUCCGCAAGGAGUAUGAAtt Ambion 
RNF40 S18962 GUACUACAGUUCAAGAACAtt Ambion 
USP22 S23566 GGAGAGAAGUUUUCAACUUtt Ambion 
 
2.5.2.2 Primers 
Experiment Name 5'-3' sequence Source 
CDK9 cloning HA-hCDK9-For GCTGACGGATCCGCCA
CCATGTACCCATACGA
TGTTCCAGATTACGCT
GAATTCATGGCAAAGC
AGTACGACTC 
GGTGGAGTGCCC 
This study 
CDK9 cloning hCDK9-Rev GTCAGCCTCGAGTCAG
AA 
GACGCGCTCAAACTCC
This study 
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GTCTG 
Nucleolin 
knockdown 
NCL50F TGGCTCCTCCTCCAAA
GGAGGT 
This study 
Nucleolin 
knockdown 
NCL235R TGGCTGGTGTGGCAAC
TGCA 
This study 
Nucleophosmin 
knockdown 
NPM250F CAGCCAACGGTTTCCC
TTGGG 
This study 
Nucleophosmin 
knockdown 
NPM375R TGACTCTGCATCTTCC
TCCACAGC 
Gomes et al, 
2006 
p21 ChIP p21 TSS F GGGGCGGTTGTATATC
AGG 
Gomes et al, 
2006 
p21 ChIP p21 TSS R GGCTCCACAAGGAACT
GACT 
Gomes et al, 
2006 
p21 ChIP p21 TR for CCAGGGCCTTCCTTGT
ATCTCT 
Gomes et al, 
2006 
p21 ChIP p21 TR rev ACATCCCCAGCCGGTT
CT 
Gomes et al, 
2006 
p21 RT-PCR p21 +8000 for_1 CTCCAGGTGGCTCTGA
GGT 
Gomes et al, 
2006 
p21 RT-PCR p21 +8000 rev_1 GCCCTTCTTCTTGTGTG
TCC 
Gomes et al, 
2006 
UBE2A cloning hRad6A HA Hind3 
For 
GCTGACAAGCTTGCCA
CCATGTACCCATACGA
TGTTCCAGATTACGCT
CAATTGATGTCCACCC
CGGCTCGGCGGCGCCT
CATG 
This study 
UBE2A cloning hRad6A XhoI Rev GTCAGCCTCGAGTCAA
CAATCACGCCAGCTTT
GTTC 
This study 
UBE2A 
mutagenesis 
hRad6A S120A C-
For 
CAATCCCAATGCTCCA
GCAAACAGCCAGGCT
GCTC 
This study 
UBE2A 
mutagenesis 
hRad6A S120A N-
Rev 
GTTTGCTGGAGCATTG
GGATTGGGTTCATCCA
AC 
This study 
USP22 cloning hUSP22For GCTGACGGATCCATGG
TGTCCCGGCCAGAGCC
CG 
This study 
USP22 cloning hUSP22Rev GTCAGCGCGGCCGCCT
ACT 
This study 
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CGTATTCCAGGAACTG
TTTG 
 
 
2.6 Proteins 
2.6.1 Protein molecular weight markers 
PageRulerTM Prestained Protein Ladder Fermentas GmbH, St. Leon-Rot 
 
2.6.2 Enzymes 
c-Jun N-terminal kinase 1 ProQinase GmbH, Freiburg 
Cyclin Dependent Kinase 9 Cell Signaling 
Phusion® High-Fidelity DNA 
Polymerase 
New England Biolabs, Frankfurt am Main 
Proteinase K Invitrogen GmbH, Karlsruhe 
Restriction enzymes New England Biolabs, Frankfurt am Main 
Reverse Transcriptase (M-
MuLV) 
New England Biolabs, Frankfurt am Main 
RNase A Qiagen GmbH, Hilden 
T4 DNA Ligase New England Biolabs, Frankfurt am Main 
Taq DNA Polymerase Prime Tech, Minsk, Belarus 
 
2.6.3 Antibodies 
2.6.3.1 Primary antibodies 
Name Clone Cat. Number WB IP IF Source 
β-Actin - ab6276-100 1:10000 - - Abcam 
CCNT1 H-245 sc-10750 1:1000 1 µg - Santa Cruz 
CDK9 C-20 sc-484  1:1000 1 µg - Santa Cruz 
Coilin Pdelta sc-56298 1:1000 - 1:50 Santa Cruz 
FLAG M2 F1804 1:10000 4 µg - Sigma 
H2B - 07-371 1:3000 - - Upstate 
H2Bub1 56 05-1312 1:5000 - 1:500 Millipore 
H2Bub1 - - - 75 
µl 
- Minsky et al, 
2008 
HSC70 B-6 sc-7298 1:25000 - - Santa Cruz 
mouse - 12-371 - 1 µg - Upstate 
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IgG 
NPM - 32-5200 1:1000 - 1:100 Invitrogen 
PCNA PC10 ab29100 1:1000 - - Abcam 
p-JNK - 46685 1:1000 - 1:100 Cell Signaling 
p-
UBE2A 
5A10 - 1:5 - - D. Eick/ E. 
Kremmer 
p-Ser2 H5 MMS-129R - 2 µl - Covance 
p-Ser2 3E10 - 1:10 - - Dirk Eick 
(Chapman et 
al, 2007) 
p-Ser5 H14 MMS-134R 1:10000 1 µl - Covance 
UBE2A - A300-282A 1:3000 - - Bethyl 
RNAPII N-20 sc-899 - 1 µg - Santa Cruz 
RNF20 - NB100-2242 1:2000 - - Novus 
Biologicals 
RNF40 - ab26082 1:1000 - - Abcam 
USP22 2391 - 1:1000 - - (Zhao et al, 
2008) 
γ-
H2A.X 
- 05-636 1:1000 - - Millipore 
 
2.6.3.2 Secondary antibodies 
 
Name Cat. 
Number 
WB IP IF Source 
Goat Anti-Mouse IgM M 8644 - 3 
µg 
- Sigma 
Donkey Anti-Mouse IgG-
HRP 
715-036-
150 
1:10000 - - Jackson 
ImmunoResearch 
Donkey Anti-Mouse IgM-
HRP 
115-035-
044 
1:3000 - - Jackson 
ImmunoResearch 
Donkey Anti-Rabbit IgG-
HRP 
711-036-
152 
1:10000 - - Jackson 
ImmunoResearch 
Goat Anti-Rat IgG + IgM-
HRP 
112-035-
068 
1:10000 - - Jackson 
ImmunoResearch 
Donkey Anti-Mouse IgG-
Alexa 488 
A21202   1:500 Invitrogen 
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2.7 Cells 
2.7.1 Bacterial cells 
Name Source 
BL21 (Ril DE3) Invitrogen  
DH10B M. Dobbelstein, GZMB, Goettingen 
 
2.7.2 Eucaryotic cells 
Name Source 
H1299 M. Dobbelstein, GZMB, Goettingen 
HCT116 WT M. Dobbelstein, GZMB, Goettingen 
HEK293 M. Dobbelstein, GZMB, Goettingen 
U2-OS M. Dobbelstein, GZMB, Goettingen 
 
2.8 Buffers and solutions 
RIPA buffer 
PBS 1X 
NP40 1% 
Na-deoxycholate 0.5% 
SDS 0.1% 
 
10X TBS-T 
Tris 0.1M 
NaCl 1.5M 
Tween-20 0.5% 
H2O to 1l 
 
Western salts 10X 
Tris 0.25M 
Materials and Methods 
 
31 
 
Glycin 0.86M 
SDS 0.7mM 
H2O to 1l 
 
PBS-T 10X (pH 7,4) 
NaCl 0,73M 
KCl 0.027M 
NaH2PO4*7H2O 14.3 mM 
KH2PO4 14.7 mM 
Tween 20 1% 
H2O to 4l 
 
Frackelton buffer 
Tris (pH 7.1) 5mM 
NaCl 25 mM 
Triton X-100 0.5% 
DTT 0.2% 
Protease and phosphatase inhibitors 1X 
 
PCR-Mix 10X 
Tris-HCl (pH 8.8) 750 mM 
(NH4)2SO4  200 mM 
Tween-20 0.1% 
 
RT-PCR Master Mix 
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PCR-Mix 1X 
MgCl2 3mM 
SYBR Green 1:80000 
dNTPs 0.2 mM 
Taq-polymerase 20U/ml 
Triton X-100 0.25% 
Trehalose 300 mM 
 
Pagano buffer 
Tris-HCl (pH 7.4) 20 mM 
DTT 2 mM 
EDTA 0.25 mM 
 
Deubiquitination buffer 
Tris-HCl (pH 7.4) 60 mM 
Glycerol 20%  
MgCl2 10 mM 
 
Blocking solution 
PBST 1X 
Milk 5% 
 
Cell culture freezing medium 
DMEM 
FBS 50% 
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DMSO 8% 
 
ChIP IP buffer 
NaCl 150 mM 
EDTA 5 mM 
Tris (pH 8) 50 mM 
NP-40 0.5% 
Triton X-100 1% 
Protease and phosphatase inhibitors 
Pefabloc 1 mM 
Aprotinin/Leupeptin 1 ng/μ l  
BGP 10 mM  
NEM 1 mM 
 
DMEM cell culture “normal” medium 
Phenol red-free, high-glucose DMEM 
FBS 10% 
Penicillin 100 U/ml 
Streptomycin 100 μg/ml  
Sodium pyruvate 1 mM 
 
6× Lämmli buffer 
Tris (pH 6.8) 0.35 M 
Glycerol 30% 
SDS 10% 
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DTT 9.3% 
Bromphenol blue 0.02% 
 
LB Agar 
LB medium 1X 
Agar 1.5% 
 
LB medium 
Peptone 1% 
Yeast extract 0.5% 
NaCl 86 mM 
 
SDS separating gel (X%) 
Acrylamide X% 
Tris-HCl (pH 8.8)  375 mM 
SDS 0.1% 
APS 0.1% 
TEMED 0.04% 
 
SDS stacking gel (5%) 
Acrylamide 5% 
Tris-HCl (pH 6.8) 125.5 mM 
SDS 0.1% 
APS 0.1% 
TEMED 0.1% 
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TAE buffer (50×) 
Tris 2 M 
Acetic acid 1 M 
EDTA 0.1 M 
 
Transfer buffer 
10× Western salts 10% 
Methanol 15% 
2YT medium 
Peptone 1.6% 
Yeast extract 1% 
NaCl 86 mM 
 
2.9 Software 
Primer designing tool NCBI/Primer-BLAST 
(www.ncbi.nlm.nih.gov/tools/primer-blast/) 
Confocal pictures 
processing 
LSM viewer, ZEISS 
 
3. Methods 
3.1 Cell culture 
Culturing cells 
H1299 (human non-small cell lung carcinoma), HEK293 (human 
embryonic kidney) and U2-OS (human osteosarcoma) cells were cultured in 
phenol red-free high-glucose Dulbecco’s modified Eagles medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS), 100 units/ml penicillin, 100 
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µg/ml streptomycin and 1 mM sodium pyruvate at 37 C under 5% CO2 
atmosphere. HCT116 (human colorectal carcinoma) cells were cultured in 
McCoy’s 5A medium supplemented with 10% fetal bovine serum (FBS), 100 
units/ml penicillin, 100 µg/ml streptomycin and 1 mM sodium pyruvate in the 
same conditions. 
 
Plasmid DNA transfection in 6-well plate 
2.4 µg of plasmid DNA were diluted in 200 µl of Opti-MEM. In a separate 
tube 8 µl of Lipofectamine 2000 were diluted in 200 µl of Opti-MEM. After 5 min 
DNA- and Lipofectamine 2000-containing solutions were mixed and incubated for 
20 min at room temperature. After the incubation transfecting mixture was added 
to a well with adherent 80%-confluent cells cowered with 2 ml of DMEM-FBS. 
After 4 h of transfection cells were washed with PBS and covered with fresh 
DMEM-FBS-P/S. 
siRNA transfection protocol in 6-well plate 
30 pmol siRNA and 5 µl RNAiMAX were diluted in 500 µl OptiMEM. 
Components were incubated at room temperature for 20 min and mixed with 2.5 
ml antibiotic-free normal growth medium containing 2.0-3.0 x 105 cells. The 
medium was replaced with a fresh one after 24 h. Cells were harvested in 48 h after 
transfection. 
Immunofluorescence 
Cells were grown on glass cover slips on a 12 well plate. After washing 
with PBS cells were fixed for 20 min with 4% formaldehyde and permeabilized for 
10 min with 0.1% TritonX-100. Further cells were blocked with Blocking Solution 
(10% FCS in PBS) for 10 min and treated with primary antibodies in Blocking 
Solution for 1-12 h. Secondary antibodies were applied in the dark for 30 min 
together with DAPI stain. Cover slips were removed from the plate and mounted 
on a glass slide for the microscopy. 
 
3.2 Molecular biology 
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Molecular cloning 
The expression constructs used in this study were created by amplifying the 
gene from cDNA using specific primers and Phugene polymerase. The product of 
PCR and appropriate vector molecule were digested with Fermantas restriction 
enzymes, gel-purified and ligated with T4 DNA ligase from Fermentas. The 
mutagenesis was performed by amplifying the plasmid with the gene using the 
primers, containing the mutation. The product of PCR was treated with DpnI to 
degrade the template DNA and transformed into E.coli DH10B cells. 
TRIZOL RNA isolation from 6-well plates 
Cells were washed twice with ice-cold PBS. 500 µl Trizol reagent were 
added to each well. Cells were scraped and transferred to 1.5 ml tube. 100 µl of 
chloroform were added followed by vortexing for 15 s. After 20 min of 
centrifugation at maximum speed, the aqueous phase was taken and washed with 
100 µl of chloroform again. The resultant solution was mixed with equal volume of 
isopropanol and kept at -20C for 2 h. The mixture was centrifuged for 20 min at 
full speed, the pellet was washed once with 500 µl of 70% ethanol and dried. Dry 
RNA was dissolved in 40 µl of DEPC water and its concentration was measured 
with a NanoDrop. 
cDNA synthesis by reverse transcription 
1 microgram of total RNA was mixed with 2ul 15uM random nonamer, 
dT23VN or combined primers and 4 µl of 2.5mM dNTPs and heated at 70 C for 5 
min. After cooling on ice 4 µl of mastermix were added, containing 10X reaction 
buffer, 10 units of RNAse inhibitors and 25 units of M-MuLV Reverse 
Transcriptase. The reaction was incubated at 42 C for 1 hour and stopped by 
heating to 95 C for 5 min. 
Real-time PCR 
14 µl of RT-PCR Master Mix were mixed with primers (final concentration 
0.3 µM), 1 µl of ChIP-DNA or cDNA and water to final volume 25 µl. The PCR 
was performed according to the following program: 
2 min – 95 C 
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15 sec – 95 C     
1 min – 60 C     x40 
Melting curve 55-95 C to ensure primer specificity 
 
Chromatin Immunoprecipitation 
ChIP analysis was performed essentially as described (Pirngruber et al., 
2009). In brief, growing medium was removed from plates and cells were 
crosslinked by adding 1.42% formaldehyde diluted in PBS. After 15 min of 
incubation at room temperature the crosslink was quenched by adding glycine to a 
final concentration of 125 mM. 5 min later cells were washed twice with PBS and 
scraped in 1 ml of ChIP buffer. All further manipulations were performed on ice or 
at 4 C. Scraped cells were cleared from the buffer by centrifugation (12000g x 10 
min) and washed again with 1 ml of ChIP buffer. After second centrifugation the 
pellet was resuspended in 300 µl of ChIP buffer and sonicated by Bioruptor (3 x 10 
min) at “H” setting with 10 s breaks between 10 s pulses. The soluble chromatin 
was cleared from the debris by centrifugation (12000g x 10 min) and pre-cleaned 
with 100 µl of 50% slurry sepharose beads for 1 hour. After the pre-clean the 
chromatin was centrifuged, aliquoted, frozen in liquid nitrogen and stored at -80 C. 
For the analysis 50 µl of chromatin were diluted up to 0.5 ml with ChIP buffer and 
incubated overnight with indicated amounts of antibodies. Immunobound 
complexes were precipitated by adding 30 µl of 50% slurry Protein-A or Protein-G 
sepharose and incubation for another 2 h. After the incubation samples were 
centrifuged (2000g x 2 min). The beads were washed with ChIP buffer 6 times and 
the crosslink was reversed by adding 10% slurry Chelex with subsequent heating 
to 95 C for 10 min. The proteins in the sample were eliminated by adding 40 µg of 
Proteinase K and incubating for 30 min at 55 C. The samples were centrifuged 
(12000g x 1 min) and the supernatant was analysed by RT-PCR. The inputs were 
prepared by precipitating the DNA from 50 µl of undiluted chromatin by standard 
ethanol precipitation. 
 
3.3 Protein biochemistry 
Kommentar [SJ1]: Might want 
to do this with your reference 
program. 
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In vitro deubiquitination 
Cells were washed with PBS and scraped in Pagano buffer. After mixing 
cells were sonicated with tip sonicator for 15 s and centrifuged at full speed to 
remove the cell debris. 1 volume of target supernatant was mixed with 1 volume of 
effector supernatant and 2 volumes of Deubiquitination buffer. The reaction was 
performed with shaking at 37 C for 15 min and stopped by adding 6X Laemmli 
buffer and heating to 95 C for 5 min. The products of reaction was analyzed by 
SDS-PAGE Western blot.  
Protein co-immunoprecipitation 
After washing with PBS cells were scraped in 1 ml Frackelton buffer. Cells 
were vortexed for 15 s and tumbled for 45 min at 4 C. Cell lysate was cleared by 
centrifugation and the supernatant was pre-cleaned by adding 50 µl of sepharose 
beads for 1 hour. The pre-cleaned supernatant was incubated with 1-3 µg of 
antibodies for 2 h and 30 µl of protein A or G coupled sepharose beads for 1 hour 
at 4 C. Beads were washed 4 times with Frackelton buffer and heated at 95 C with 
70 µl of 2X Laemmli buffer. The supernatant was analyzed by SDS-PAGE and 
Western blot.  
GST protein purification 
BL21 E. coli strain containing a plasmid coding for an appropriate gene 
under GST tag was grown in 2X YT medium to the OD600 300, then induced with 
1 mM IPTG and incubated overnight at 16 C. The bacteria were harvested by 
centrifugation and lysed in a GST Lysis Buffer containing 0.2 mg/ml Lysozyme. 
Cells were lysed by sonication (5 pulses 30 s each, full power). The solution was 
cleared by centrifugation and incubated with glutathione-sepharose beads for 2 h at 
4 C. After triple washing with GST Lysis Buffer protein was eluted with 25 mM 
glutathione in Lysis Buffer for 1 hour at 4 C. Eluted protein was analyzed by SDS-
PAGE and measured by Coomasie staining in comparison to the serial dilution of 
BSA, then stored at -80 C. 
In vitro kinase assay 
150 ng of recombinant kinase were diluted in 20 µl of Kinase buffer and 
incubated for 30 min at 30 C to block all possible auto-phosphorylation sites with 
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non-radioactive phosphates. After that 500 ng of target protein and 50uCi of γ[32P]-
ATP in kinase buffer were added to the final volume of 30 µl. The reaction was 
performed for 20 min at 30 C and stopped by adding 6X Laemmli buffer and 
heating up to 95 C for 5 min. Later it was separated by SDS-PAGE, the gel was 
dried and analyzed by phosphoimager to detect the phosphorylated proteins. 
 
SDS-PAGE 
Protein extracts were separated by sodium dodecylsulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) (Laemmli, 1970). Adherent cells were lysed with 
RIPA buffer with Pefabloc (1 mM), Aprotinin/Leupeptin (1 ng/ul), betaglycerol 
phosphate (10 mM) and N-ethylenmaleimid (1 mM). The extracts were then 
sonicated for 15 s with Bandelin Sonoplus tip sonicator to shear the genomic DNA. 
The extracts were mixed with Laemmli buffer and heated at 95 C for 5 min. 
Proteins were separated in 8% or 15% acrylomide gels in SDS running buffer at 25 
mA. 
Western blot analysis 
Separated proteins were transferred to nitrocellulose membranes by 
Western blot procedure (Towbin et al., 1979). The transfer was performed at 100V 
for 1 hour using Transfer buffer. The membrane was blocked in Blocking solution 
(PBS-T with 5% dry milk) and incubated overnight with primary antibodies 
diluted in Blocking solution. On the next day the membrane was washed 3 times 
with PBS-T and incubated for 1 hour with secondary HRP-coupled antibodies in 
Blocking solution. After the incubation the membrane was washed with PBS-T 3 
times and developed using the enhanced chemoluminiscence solution and X-ray 
films.
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4. Results 
In this study different mechanisms of regulation of H2B 
monoubiquitination were examined.  
First, the role of P-TEFb complex in maintaining the level of H2Bub1 was 
described. P-TEFb was found to be responsible not only for gene-specific but also 
for a global level of H2B ubiquitination. 
Second, the role of UBE2A regulation by CDK9 through site-specific 
phosphorylation has been demonstrated. The ubiquitination of PCNA, another 
target of UBE2A, was also shown to be dependent upon P-TEFb activity. 
The last part of this study describes strong and rapid loss of H2B 
monoubiquitination caused by various stress-inducing factors, such as 
chemotherapeutics, µltraviolet radiation, osmotic shock, etc. The signaling and 
deubiquitinating enzymes responsible for this global epigenetic shift were 
identified. 
 
 
4.1 CDK9 positively regulates global and gene-specific levels of H2B 
monoubiquitination. 
4.1.1 CDK9 activity is necessary for supporting global level of H2Bub1. 
Since phosphorylation of Ser2 of RNAPII CTD and H2Bub1 have the same 
pattern of accumulation on a gene, we hypothesized that the activity of the P-TEFb 
complex including CDK9 and CCNT1 is important for H2B monoubiquitination. 
H1299 cells treated with different inhibitors of CDK9 demonstrated a loss of 
H2Bub1 (Fig. 10A). The overexpression of the recombinant CDK9 led to the 
increased p-Ser2 and H2Bub1, whereas the knockdown of CDK9 by a specific 
siRNA caused a strong reduction of p-Ser2 as well as H2Bub1 (Fig. 10B,C). 
RNAPII carboxy-terminal domain (CTD) phosphatases SCP1, SCP2 and SCP3 
were found to have high specificity towards Ser2 in comparison to Ser5 (Fig. S1). 
The overexpression of these phosphatases reduced both the phosphorylation of 
Ser2 of RNAPII CTD and monoubiquitination of H2B (Fig. 10D). 
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To address the question whether Ser2 of RNAPII CTD is really the target 
of CDK9 which regulates H2Bub1 the following experiment was performed. 
Recombinant large RNAPII subunits resistant to α-amanitin and having either wild 
type or mutated CTD were overexpressed in HEK293 cells. The cells were treated 
with α-amanitin for 48 h to block all the transcription by endogenous RNAPII. The 
result of the experiment clearly shows that cells which had no CTD or CTD with 
S2A mutations had a significantly lower level of global H2B monoubiquitination 
whereas cells with wild type CTD or S5A mutations maintain a similar levels of 
H2Bub1 (Fig. 10E). 
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Figure 10. CDK9 activity and RNAPII CTD Ser2 phosphorylation regulate H2B 
ubiquitination. A. H1299 cells were treated with 10, 50 and 100 µM of CDK9 inhibitors 5,6-
dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) and 8-(methylthio)-4,5-
dihydrothieno[3',4':5,6]benzoisoxazole-6-carboamide (KM05283) for 4 h and analyzed by 
Western blot. B. H1299 cells were transfected with an empty vector or recombinant hCDK9 
expression vector. Following 48 h of expression cell extracts were analyzed by Western blot. C. 
H1299 cells were transfected with control or anti-CDK9 siRNAs for 48 h and analyzed by 
Western blot. D. H1299 cells were transfected with plasmids encoding for FLAG-tagged CTD 
phosphatases SCP1, SCP2 and SCP3. 72 h after transfection protein extracts were analyzed by 
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Western blot with specified antibodies. E. HEK293 cells were transfected with plasmids 
encoding α-amanitin resistant large RNAPII subunit with different mutations in the CTD. After 
24 h of expression cells were grown in medium containing 10 mM α-amanitin for another 48 h. 
Protein extracts were analyzed by Western blot.  
 
4.1.2 CDK9, not transcription per se is required for maintaining H2Bub1 
on an actively transcribed gene. 
In an attempt to test whether CDK9 activity plays a positive role in the 
maintaining H2B ubiquitination on a single gene chromatin immunoprecipitation 
analyses were performed using the p21 gene as a model system. The p21 gene is 
unique in that it could be transcribed in the absence of active P-TEFb complex 
(Gomes et al, 2006). The gene was induced by two different chemicals. First, 
Nutlin-3A, is a selective inhibitor of HDM2, the E3 ubiquitin ligase that targets 
p53 for proteosomal degradation. Following Nutlin-3A treatment the 
polyubiquitination and subsequent degradation of p53 is blocked which leads to its 
rapid accumulation and induction of p53-regulated genes, such as p21 (Vassilev et 
al, 2004). DRB (5, 6-dichloro-b-D-ribofuranosyl benzimidazole) can also induce 
transcription of some p53 target genes while paradoxically inhibiting CDK9 
activity.  
 
Due to the different nature of the two drugs the dynamics of p21 induction 
are different as well. A time-course of the two drugs was performed to estimate an 
appropriate time point for the experiment. As seen from the graph in 8 h after the 
treatment both drugs actively induced p21 expression (Fig. 11A). 
 
 Both Nutlin-3A and DRB increased the occupancy of RNAPII to the 
transcribed region (Fig. 11B, C), whereas only upon Nutlin-3A treatment did the 
CTD of RNAPII remain phosphorylated at Ser2 since DRB prevents this 
phosphorylation by inhibiting CDK9 (Fig. 11D). In accordance with our model 
H2B ubiquitination is detected only following Nutlin-3A-induced gene induction 
while the transcription of p21 in the absence of CDK9 activity does not lead to the 
accumulation of this transcription-related chromatin mark (Fig. 11E).  
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Figure 11. H2Bub1 depends on CDK9 activity but not on transcription per se. A. 
Nutlin-3A and DRB induce p21 expression. U2OS cells were treated with 8 µM of Nutlin-3A 
and 50 µM of DRB for 4, 8, 16 and 24 h. RNA was extracted and reverse transcribed. The cDNA 
was analyzed by real-time PCR and results were normalized to mitochondrial 16S rRNA. B-E. 
H2Bub1 increases on the p21 gene only in the presence of Ser2-phosphorylated RNAPII. U2OS 
cells were treated with Nutlin-3A and DRB for 8 h and the chromatin was immunoprecipitated 
using the antibodies against total RNAPII (B,C), pSer2 RNAPII (D) and H2Bub1 (E). 
Chromatin was analyzed by real-time PCR, the data was normalized to input DNA and expressed 
as percent of recovery, mean values + standard deviation, n=3. Dotted lines represent the 
experimental background. TSS - transcription start site, TR – transcribed region. 
 
 
4.2 CDK9 regulates UBE2A by site-specific phosphorylation 
 
4.2.1 CDK9 and CCNT1 interact with UBE2A 
UBE2A (hRad6A) is an E2 ubiquitin conjugating enzyme involved in the 
ubiquitination of histone H2B and DNA clamp PCNA. In yeast Rad6A is activated 
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by phosphorylation of serine 120. The kinase responsible for this phosphorylation, 
called Bur1 (Wood et al, 2005) is homologous to human CDK9. Furthermore, the 
human homolog UBE2A was also shown to be phosphorylated at the same position 
by other cyclin-dependent kinase members (Sarcevic et al, 2002). We hypothesized 
that human UBE2A function may also be regulated by CDK9-mediated site-
specific phosphorylation. 
In order to test whether CDK9 and UBE2A interact in human cells we 
performed coimmunoprecipitation studies between the kinase and its putative 
substrate. We were able to successfully demonstrate the binding of endogenous 
UBE2A with CDK9 and Cyclin T1 (Fig. 12A) as well as CDK9 with UBE2A (Fig. 
12B). 
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Figure 12. UBE2A interacts with CDK9 and CCNT1. H1299 cells were harvested 
and coimmunoprecipitation was performed using the antibodies against endogenous CDK9, 
Cyclin T1 (A) and UBE2A (B) as well as unspecific IgGs. The presence of 
coimmunoprecipitated proteins was detected by Western blot with specific antibodies. 
4.2.2 CDK9 phosphorylates UBE2A in vitro and in vivo 
Besides the binding we also wanted to demonstrate site-specific kinase 
activity of CDK9 towards UBE2A. For that wild type UBE2A as well as S120A 
mutant were purified from E. coli as GST-fusion proteins and phosphorylated by 
CDK9 in vitro using γ-[32P]-ATP. Serine 120 is homologous to the yeast Rad6 
phosphorylation site (also S120) of human UBE2A. By mutating it to alanine we 
expected to abolish the CDK9-mediated phosphorylation.  
While GST alone and the S120A mutant of UBE2A were only mildly 
phosphorylated (Fig. 13A), wild-type GST-UBE2A was significantly 
phosphorylated by P-TEFb in vitro. After quantifying the intensity of bands and 
normalizing them to the molecular weights of proteins the specificity of P-TEFb 
for S120 became clear, since the S120A mutant was phosphorylated at a level 
similar to GST alone (Fig. 13B).  
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 In collaboration with Dirk Eick and Elisabeth Kremmer (Helmholtz Center 
for Environmental Health, Center for Integrated Protein Science, Munich) we 
generated a mouse monoclonal antibody that specifically recognizes S120-
phosphorylated form of UBE2A. Importantly, the signal of this antibody in 
Western blot is strongly decreased following the knockdown of either CDK9 or 
UBE2A suggesting that the phosphorylation of UBE2A in vivo depends on CDK9 
activity (Fig. 13C). 
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Figure 13. CDK9 phosphorylates UBE2A in vitro and in vivo. A. GST-UBE2A 
fusions were phosphorylated by CDK9 in the presence of γ-[32P]-ATP. Arrows indicate specific 
bands obtained with phosphoimager. High molecular weight bands represent the products of 
auto-phosphorylation of kinase complex components. B. Quantification of band intensity was 
performed using TYPHOON Scanner Control 3.0 software. Results were normalized to the 
protein size and presented as fold relative to GST background. C. HCT116 cells were transfected 
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with siRNAs against CDK9 or UBE2A. Protein extracts were analyzed by Western blot 48 h 
after transfection.  
4.2.3 CDK9 is necessary for both H2B and PCNA monoubiquitination 
As is typical for most E2 ubiquitin conjugating enzymes, UBE2A supplies 
the ubiquitin for several E3 ubiquitin ligase complexes. In this case RAD18 and 
RNF20/40 which ubiquitinate PCNA and H2B, respectively, both utilize UBE2A 
for substrate ubiquitination (Kim et al, 2009; Watanabe et al, 2004). Assuming that 
CDK9 might regulate UBE2A function we hypothesized both ubiquitinations may 
be affected by changing the level of CDK9. Indeed, the reduction of PCNA and 
H2B monoubiquitinations in UVC-treated CDK9-depleted cells was comparable to 
the effect of knocking down UBE2A alone (Fig. 14A).  
Cyclin T1 is the major cyclin component of P-TEFb and is known to be 
necessary for its activity (Peng et al, 1998). As predicted by our model the 
depletion of CCNT1 also led to the reduction of H2B monoubiquitination as well 
as PCNA monoubiquitination following the treatment by UVC and hydroxyurea 
(Fig. 14B). 
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Figure 14. CDK9 regulates PCNA monoubiquitination. A. HCT116 cells were 
transfected with siRNAs against CDK9 or UBE2A. After 48 h 80J/m2 UVC was applied and 
cells were harvested 3 h later. B. HCT116 cells were transfected with a control siRNA or an 
siRNAs against Cyclin T1. 80J/m2 UVC and 3mM of hydroxyurea were applied 3 and 20 h 
before harvesting protein extract. 
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4.3. H2B is rapidly deubiquitinated following various stress conditions 
4.3.1. Different stress factors rapidly reduce H2B monoubiquitination 
As shown in the previous chapter treatment with µltraviolet light drastically 
reduced the levels of H2Bub1 (Fig. 14A). In the course of this study we observed a 
severe reduction of histone H2B monoubiquitination caused by a wide palette of 
factors, such as DNA-damaging chemotherapeutic drugs (doxorubicin, 
camptothecin, etoposide, cisplatin, hydroxyurea), proteasome inhibitors (MG132), 
heat shock, osmotic stress and nucleolar function disruption (Fig. 14B, 15A, S2). 
Surprisingly we were able to rescue this effect by pre-treating the cells with 
caffeine, which is widely used to inhibit the activity of PI3-kinase-related protein 
kinases following DNA damage (Fig. 15B). 
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Figure 15. Various factors downregulate the H2B ubiquitination. A. H1299 cells 
were treated for 1 h with 7.5 µM doxorubicin, 10 µM camptothecin, 100 µM etoposide, 20 µM 
MG132, 30 µM KM05283 and 0.5 M sorbitol. Protein extracts were analyzed by Western blot. 
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B. H1299 cells were pretreated with 4 mM of caffeine for 1 h, then treated with 7.5 µM 
doxorubicin for 3.5 h. Protein extracts were analyzed by Western blot. 
The chemotherapeutic drugs used in this study cause the formation of 
single- or double-strand DNA breaks. Ultraviolet light, heat shock and osmotic 
stress can also act as DNA-damaging factors. Caffeine which is able to rescue the 
H2Bub1 is a well known inhibitor of DNA damage response PI3-kinases. 
Therefore, we further tested whether DNA damage per se causes a loss of H2B 
ubiquitination. Surprisingly, cells irradiated with 10 Gy of γ-radiation showed no 
significant decrease of H2Bub1 (Fig. 16A). Moreover, in a concentration course of 
the DNA-damaging drug doxorubicin we can clearly see that the cells develop a 
strong DNA-damage response (as indicated by the level of γH2AX) at 
concentrations which do not affect H2Bub1 (Fig. 16B). We therefore analyzed 
several signaling pathways which are known to be activated by cell stress and 
potentially lie downstream of the effects of caffeine to determine if these are 
involved in the stress-induced loss of H2Bub1. As seen from Table 1 only a few of 
these could rescue the post-stress H2Bub1 levels. 
Target Rationale Inhibition Effect  
ATM inhibited by caffeine (Sarkaria et al, 1999) KU55933, siRNA - 
ATR inhibited by caffeine (Sarkaria et al, 1999) siRNA - 
DNA-PK inhibited by caffeine (Block et al, 2004) siRNA - 
PI3Ks Include ATM, ATR and DNA-PK Wortmannin  - 
JNK Stress-activated (Ip & Davis, 1998) SP600125 + 
p38 Stress-activated (Roux & Blenis, 2004) SB203580 - 
PP1, 2A CDK9 phosphatases (Chen et al, 2008) Okadaic acid  - 
PP2B CDK9 phosphatases (Chen et al, 2008) Cyclosporin A - 
PARP Activated by stresses (Nicoletti & Stella, 2003) Olaparib  - 
mTOR  stress-activated (Reiling & Sabatini, 2006) Rapamycin  - 
G-protein regulates cAMP level, as caffeine does Cholera toxin  - 
ROS Produced by various stresses NAC/Trolox - 
DUBs remove ubiquitin tags NiCl2/IAA + 
 
Table 1. Signaling pathways analyzed in the course of the study. 
Most of these drugs used require transport mechanisms and subsequent 
steps in order to get inside the cell and cause the damage. Thus in order to analyze 
the dynamics of H2Bub1 reduction we treated cells with ultraviolet radiation and 
followed the effects of treatment on global H2Bub1 levels. From the results of a 
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time course treatment it is clear that most of H2Bub1 loss happens within 15 min 
after the treatment indicating that H2B ubiquitination and deubiquitination are very 
fast and highly dynamic processes (Fig. 16C). 
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Figure 16.The reduction of H2B ubiquitination happens rapidly but is not caused 
by DNA damage per se. A. H1299 cells were irradiated with 10 Gy γ-irradiation 1 and 3 h 
before harvesting for Western blot analysis. B. H1299 cells were treated with the indicated 
concentrations of doxorubicin for 3.5 h, proteins were analyzed by Western blot. C. H1299 cells 
were treated with UVC (80 J/m2) and harvested for Western blot after indicated times.  
4.3.2. Nucleolar function is necessary for maintaining H2B ubiquitination 
Nucleoli are known to quickly respond to different stress factors by 
exchanging their components with the nucleoplasm (Boulon et al, 2010). Some 
consider nucleoli to be one of the most important stress sensors in the cell (Mayer 
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et al, 2005; Olson, 2004). We hypothesized that this effect could be involved in the 
regulation of H2Bub1 upon stress. At low concentrations Actinomycin D is a 
potent RNAPI inhibitor and can rapidly disrupt the function of nucleoli by 
blocking ribosomal RNA transcription (Perry & Kelley, 1968). Concentration 
course studies showed that the decrease of H2Bub1, stress-induced release of the 
nucleolar protein nucleophosmin (NPM) and activation of the stress-responsive 
kinase JNK happen in the same range of concentrations (Fig. 17A, B, S3). 
Nucleophosmin and nucleolin are two important components of nucleoli 
and are essential for proper rRNA processing and ribosomal subunits biogenesis 
(Ginisty et al, 1998; Lindstrom, 2011). Nucleophosmin is a chaperone and one of 
its functions is retaining the ARF protein in the nucleolus (Colombo et al, 2005). 
Upon stress-induced nucleoplasmic translocation NPM releases ARF to the 
nucleus where it can trigger p53-signaling in previously described manner. The 
knockdown of nucleophosmin and nucleolin led to the reduction of H2B 
ubiquitination indicating that ribosomal function is needed for H2Bub1 
maintanence. Since the cells used in the experiment were p53-negative it is 
unlikely that the observed effects depend on the p53 pathway. (Fig. 17C, D). 
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Figure 17. Disruption of nucleolar function causes a loss of histone H2B 
monoubiquitination. A. H1299 cells were treated with the indicated concentrations of 
actinomycin D for 3.5 h. Protein extracts were subjected to Western blot analysis. B. H1299 cells 
were treated with the indicated concentrations of actinomycin D for 3.5 h and immunostained 
with antibodies against nucleophosmin. White arrows indicate individual nucleoli with or 
without nucleophosmin. C. H1299 cell were transfected with siRNAs against nucleophosmin and 
nucleolin. After 48 h after transfection total RNA was harvested, reverse transcribed and 
analyzed by RT-PCR. The results were normalized to 36B4 expression and presented as percent 
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of expression. n=3, error bars represent standard deviation D. H1299 cell were transfected with 
siRNAs against nucleophosmin and nucleolin. In 48 h after transfection cells were harvested and 
protein extracts were analyzed by Western blot. 
Nucleoli tightly interact with specific subnuclear structures involved in 
snRNA maturation referred to as Cajal bodies (Kiss et al, 2006). This interaction is 
mediated by protein migration. We observed a massive migration of one of the 
main Cajal body structural proteins, Coilin, to the periphery of the nucleoli 
following the induction of stress response by the same factors that induce the loss 
of H2Bub1. Interestingly, same as H2B ubiquitination, proper localization of 
Coilin can be rescued by caffeine treatment (Fig. 18). 
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Figure 18. Disruption of Cajal bodies structure upon stress can be rescued by 
caffeine. H1299 cells were pretreated with 4 mM caffeine for 30 min and treated with 7.5 µM 
doxorubicin, 10 µM camptothecin and 50 J/m2 UVC. After 3.5 h cells were fixed and stained 
with antibodies against Coilin (yellow) and with DAPI (cyan). Stars represent nucleoli, arrows 
show intact Cajal bodies. Scale bar is 10 µm. 
 
4.3.3. JNK activity regulates the level of H2B ubiquitination  
Activation of JNK is a hallmark of various stress inducers. Therefore, we 
used a specific JNK inhibitor SP600125 to determine whether increased JNK 
activation might be essential for the stress-induced loss of H2Bub1. Indeed, pre-
treatment with the JNK inhibitor partially blocked the ability of doxorubicin or 
actinomycin D to decrease global H2Bub1 levels (Fig. 19A, S4).  
Further support for the role of JNK in this process was provided by 
overexpressing it together with constitutively active form of its activating kinase 
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MEKK1. As seen from the results of Western blot and immunofluorescence 
staining, the overexpression of activated JNK leads to the reduction of H2B 
ubiquitination (Fig. 19B, C). Furthermore, the effect of overexpression can be 
rescued by the treatment with the JNK inhibitor (Fig. 19D). 
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Figure 19. JNK activity regulates the level of H2B ubiquitination. A. H1299 cells 
were pretreated with 20 µM of JNK inhibitor SP600125 for 30 min before 3.5 h treatment with 
7.5 µM of doxorubicin. Proteins were analyzed by Western blot. B, C. H1299 cells were 
transfected with control vector or plasmids encoding human JNK1 and its activator MEKK1. 
After 24 h cells were (B) harvested for Western blot or (C) stained with antibodies against 
H2Bub1 (green) and phospho-JNK (red). White arrows indicate the nucleus of the cell with 
overexpressed activated JNK. D. H1299 cells were transfected as in B and 24 h later treated with 
20 µM of SP600125 for 3 h before harvesting for Western blot. 
 
4.3.4. H2Bub1 levels are reduced due to the activation of a cellular 
deubiquitinating enzyme 
We questioned whether the activity of deubiquitinating enzymes (DUBs) is 
responsible for the rapid removal of H2B ubiquitination following cellular stress. 
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Two wide range DUBs inhibitors, NiCl2 and iodacetamide (IAA), significantly 
rescued doxorubicin or actinomycin D induced decrease in H2Bub1 (Fig. 20A).  
However, based on the data it is not clear whether the effects of NiCl2 and 
IAA are due to the basal level of DUB activity (i.e. the loss of H2Bub1 is primarily 
caused by decreased ubiquitination) or whether a specific DUB activity is 
increased. In order to clarify this question we performed an in vitro 
deubiquitination experiment (Fig. 20B). In brief, protein extracts from normal cells 
(substrate) were mixed with extracts from cells where RNF20 and RNF40 were 
depleated with siRNA to minimize the level of H2Bub1 (effector). The reaction 
buffer was added to the mixed extracts and they were incubated at 37 C. After 
mixing the substrate extract with the control effector extract we observed no 
change of H2Bub1 meaning that neither additional ubiquitinated H2B nor any 
appreciable DUB activity were present in the control effector extract. Note that the 
level of total H2B doubled at the same time due to additional histones present in 
the effector extracts. When the doxorubicin-treated cells were used for the effector 
extract the amount of H2B ubiquitination dropped below the basal level indicating 
that an increased deubiquitinating activity was present in treated cells (Fig. 20C). 
In order to prove that the loss of ubiquitination caused by the presence of 
the doxorubicin-induced effector extract was provided by DUBs we performed 
another in vitro deubiquitination experiment with DUB inhibitors. The result 
clearly shows all three DUB inhibitors were able to successfully rescue the level of 
H2B ubiquitination (Fig. 20D). 
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Figure 20. An H2B deubiquitinating activity is increased during cellular stress. A. 
H1299 cells were pretreated with 1 mM of NiCl2 and 1 µM of iodacetamide for 30 min before 
treatment with 3.75 µM doxorubicin or 256 nM actinomycin D for 3.5 h. Protein extracts were 
analysed by Western blot. B. Scheme of the in vitro deubiquitination experiment. For details see 
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“Materials and methods”. C. H1299 cells were transfected with control or RNF20/40 siRNA and 
treated with 7.5 µM doxorubicin for 3.5 h prior to harvesting and performing in vitro 
deubiquitination assay. D. Cells were treated same way as in C, but DUB inhibitors (IAA 1 µM, 
NEM 1mM, NiCl2 1mM) were added to the reaction mix. 
4.3.5 USP22 is needed for the stress-induced JNK-regulated 
deubiquitination 
USP22 has been shown to deubiquitinate nucleosomes containing 
monoubiquitinated H2B in vitro. We hypothesized that its activity could be crucial 
for the stress-induced deubiquitination as well. As shown in Fig. 21A and 
supplementary Fig. S5 siRNA-mediated knockdown of USP22 rescues the H2B 
ubiquitination after treatment with actinomycin D or the DNA-damaging drug 
cisplatin.  
Knowing the role of USP22 in H2B deubiquitination and the importance of 
JNK activity for this process we suggested the possibility that JNK may directly 
regulate USP22 activity through phosphorylation. Therefore we performed in vitro 
kinase assays using GST-tagged E. coli-purified USP22 as a substrate for 
recombinant JNK in the presence of γ-[32P]-ATP. We could observe specific 
phosphorylation of USP22 by JNK while phosphorylation of GST alone was 
nearly undetectable (Fig. 21B). 
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Figure 21. USP22 regulates the level of H2Bub1 and can be phosphorylated by 
JNK. A. H1299 cells were transfected with siRNAs against USP22. After 48 h cells were treated 
with 50 nM of actinomycin D for 3.5 h. Extracts were analyzed by western blot. B. GST-USP22 
fusion protein was phosphorylated in vitro by JNK in presence of γ-[32P]-ATP. The products of 
the reaction were separated by SDS-PAGE and analysed with phosphoimager. Black arrows 
indicate phosphorylated full-size GST-USP22, autophosphorylated JNK and GST. Other bands 
are phosphorylated degradation products of GST-USP22.  
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Figure S1. SCP1, SCP2 and SCP3 dephosphorylate Ser2 but not Ser5 of RNAPII 
CTD. H1299 cells were transfected with plasmids coding for SCP1, SCP2 and SCP3. After 48 h 
cells were harvested for and analyzed by Western blot using the indicated antibodies. 
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Figure S2. Heat shock reduces H2B ubiquitination. H1299 cells were heat-shocked 
by incubation at 42 C for 1 h. Protein extracts were analyzed by Western blot. 
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Figure S3. Activation of JNK correlates with the reduction of H2Bub1. H1299 cells 
were treated with indicated concentrations of actinomycin D for 12 h. Proteins were analyzed by 
Western blot using the indicated antibodies. These data were kindly provided by Theresa 
Gorsler. 
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Figure S4. JNK inhibitor rescues H2Bub1 level after actinomycin D treatment. 
H1299 cells were pretreated with 20 µM of JNK inhibitor SP600125 for 1 h and then treated 
with 256 nM of actinomycin D for 3.5 h. Protein extracts were harvested and analyzed by 
Western blot. 
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Figure S5. USP22 is needed for cisplatin-mediated reduction of H2Bub1. H1299 
cells were transfected with siRNA against USP22. After 48 h cells were treated with 50 µM 
cisplatin for 12 h. Protein extracts were analyzed by Western blot using the indicated antibodies. 
These data were kindly provided by Theresa Gorsler. 
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5 Discussion 
Gene transcription is a tightly regulated process. It is controlled at all stages 
from initiation complex formation to the processing of the 3’-end of the transcript. 
One of the important regulatory steps is a decision to switch the paused RNA 
polymerase complex to the elongation mode. The importance of pausing the 
transcription for the gene regulation became more obvious in recent years. The 
paused polymerase can wait for the induction for quite a long time providing the 
cell the possibility to rapidly activate transcription. In yeast two thirds of genes 
with paused RNA polymerase appeared to belong to the groups encoding the 
factors of cellular metabolism reprogramming (Radonjic et al, 2005). Besides that, 
pausing also provides the chance for improperly assembled transcription complex 
to fall off. In humans about 30% of all genes were shown to have a significant 
amount of RNA polymerased paused in the proximal promoter region while not 
not producing any detectable amount of RNA (Guenther et al, 2007). The release 
of RNAPII from pausing is primarily regulated by the Positive Transcription 
Elongation Factor-b (P-TEFb) (Yamada et al, 2006). The posttranslational 
modification of histones plays an important regulatory role in coordination of 
transcription events. Monoubiquitination of lysine 120 of histone H2B (H2Bub1) 
is an elongation epigenetic mark of actively transcribed genes (Minsky et al, 2008). 
Despite the high occupancy of H2Bub1 in the transcriptionaly active fraction of the 
genome relatively little is known about its regulation during the transcription cycle 
as well as the dynamics of this mark in different physiological conditions. 
 
5.1 P-TEFb as a key regulator of transcription elongation and co-
transcriptional histone modification 
P-TEFb is known to regulate the elongation step of transcription. Its kinase 
component CDK9 phosphorylates multiple target proteins. The phosphorylation of 
the NELF-E subunit of the Negative Elongation Factor leads to its release from the 
paused RNA polymerase complex (Fujinaga et al, 2004). Another negative 
elongation factor, DSIF, stays associated with RNAPII and is converted to a 
positive elongation factor upon CDK9-mediated phosphorylation (Yamada et al, 
2006). The RNA polymerase II itself can also be phosphorylated by CDK9 at 
second serine residues of its carboxy-terminal domain repeats. This not only 
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changes the charge and conformation of the CTD but also provides a binding 
surface for RNAPII associated factors (Buratowski, 2003; Egloff & Murphy, 
2008). 
Based on a similar distribution pattern of H2Bub1 and P-TEFb-mediated 
RNAPII CTD Ser2 phosphorylation in human cells (Gomes et al, 2006; 
Komarnitsky et al, 2000; Minsky et al, 2008) we hypothesized that P-TEFb activity 
might be essential for the accumulation of H2Bub1. Indeed we were able to show 
that both inhibition and knockdown of the P-TEFb kinase component CDK9 
resulted in a strong decrease of H2Bub1 levels while the overexpression of CDK9 
had an opposite effect on H2Bub1. We were also able to convincingly show that 
Ser2 in RNAPII CTD is at least one of the CDK9 targets whose phosphorylation is 
needed for maintaining H2B ubiquitination. Although H2Bub1 was thought to be a 
co-transcriptional histone mark we were able to prove that it’s only observed on a 
gene, which is being transcribed by CDK9-phosphorylated RNAPII. It is not 
detected in the presence of non-phosphorylated RNAPII in cases when the 
transcription happens in the absence of active P-TEFb. The recent discovery of a 
new role of Ww domain-containing Adaptor with Coiled-coil (WAC) protein 
provided a solid support for our model (Zhang & Yu, 2011). WAC was shown to 
be a physical link between phospho-RNAPII and H2Bub1. It can simultaneously 
bind phosphorylated RNAPII CTD and heterodimeric complex of E3 ubiquitin 
ligases RNF20/40 which ubiquitinates histone H2B.  
The P-TEFb complex has been shown to regulate not only RNA 
polymerase dynamics but also the co-transcriptional modifications of chromatin. 
The histone methyl transferase SETD2 is recruited to the CDK9-phosphorylated 
RNAPII CTD (Egloff & Murphy, 2008). This leads to the increase of H3K36 
trimethylation in the transcribed region of the gene. In addition, H2B 
monoubiquitination can itself regulate the deposition of tri-methyl marks on H3K4 
and H3K79 by a trans tail regulation mechanism while its own regulation remains 
elusive in many aspects (Kim et al, 2005; Zhu et al, 2005).  
Other targets of CDK9 appeared to be less important for maintaining 
H2Bub1 level. The knockdown of NELF-E affected neither H2Bub1 nor H3 
methylations dependent on it. The knockdown of the DSIF component SUPT5H 
also did not change the level of H2Bub1 while the amount of H3K36me3 was 
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significantly reduced, proving that H3K36me3 is regulated by additional factors 
besides RNAPII phosphorylation. Both H2Bub1 and H3K36me3 are 
predominantly localized in the transcribed part of the gene, however different 
regulation suggests different roles. Indeed, unlike ubiquitously distributed H2Bub1 
H3K36me3 is highly enriched on exons (Kolasinska-Zwierz et al, 2009). This 
localization was found to be connected to pre-mRNA splicing (Luco et al, 2011). It 
also should be mentioned that some published data is contradictory to our 
observations. The siRNA-mediated knockdown of SUPT5H was shown to strongly 
decrease the level of H2Bub1 in human cells (Chen et al, 2009). Additional 
experiments involving another siRNAs and probably the rescue experiment are 
needed to clarify the situation. In accordance with previously shown data that 
H2Bub1 regulates H3K4me3 and H3K79me3 we were able to demonstrate a strong 
downregulation of all these marks following the CDK9 knockdown (Pirngruber et 
al, 2009a). 
Despite playing a significant role in the coordination of other chromatin 
marks H2Bub1 may also play an important role in transcription by itself. As was 
recently observed the ubiquitination of H2B disrupts the structure of the chromatin 
at the level of the 30 nm fiber (Fierz et al, 2011). This structural change could 
promote the transcription by opening it for RNAPII. However, previous reports 
suggest otherwise. The rate of in vitro transcription did not depend on the presence 
of ubiquitin tags on histones (Kim et al, 2009). The most probable role of H2Bub1 
in this case is regulation of other histone modifications which might be more 
important for the transcription rate. At the same time other researchers reported 
direct stimulating effect of H2Bub1 on in vitro transcribing RNAPII. A model was 
proposed where H2Bub1 acts as a mark for the FACT complex to remove the 
H2A/H2B dimer from the nucleosome thus promoting the movement of RNAPII 
through the chromatin (Pavri et al, 2006). In general, this provides a novel 
mechanism of transcriptional regulation by P-TEFb through H2Bub1. 
 5.2 P-TEFb and genome integrity 
Despite having a significant role in the regulation of transcription, P-TEFb 
or at least its kinase component CDK9, is clearly involved in maintaining genome 
integrity. CDK9 was recently isolated in a screen as a HU-sensitivity factor (Yu et 
al, 2010). Cells lacking CDK9 were less able to recover from HU-induced cell 
cycle arrest. Cyclin K was shown to be necessary as the CDK9 partner for this 
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activity. The accumulation of γH2A.X in cells depleted of CDK9 was also 
observed suggesting the inability of cells to repair spontaneous DNA breaks. The 
interaction of CDK9 with DNA damage-related proteins ATR, ATRIP and Ku70 
also provides good evidence for the role of CDK9 in genome integrity maintenance 
(Yu et al, 2010). However, based on these studies the exact mechanism of CDK9-
mediated control of DNA damage repair remains unknown. 
The yeast CDK9 homolog Bur1 may also be important for DNA damage 
repair. It specifically phosphorylates and activates Rad6, an E2 ubiquitin ligase for 
PCNA. PCNA is a DNA clamp and in its ubiquitinated state recruits DNA 
polymerase eta for the translesion synthesis (Haracska et al, 2001). It is also worth 
mentioning that the putative phosphorylation site in the human Rad6 homolog 
UBE2A likely plays an important role in the regulation of its function. Many other 
members of the UBE family have single or double negatively charged aminoacids 
in the site where UBE2A has a phosphorylatable serine (Fig. 22). It appears that a 
strong negative charge in this region is essential for protein function.  
120
 
Figure 22. Analysis of UBE-family members. Serine is substituted to one or two 
negatively charged amino acids in multiple homologues of UBE2A. (Done by ClustalW 
software). 
We hypothesized a positive role for CDK9 in the regulation of the human 
Rad6 homolog UBE2A. Indeed CDK9 and cyclin T1 can bind a UBE2A and 
phosphorylate it in vitro at the conserved serine 120. Moreover, the antibody raised 
against a UBE2A phosphopeptide showed a decreased signal after siRNA-
mediated CDK9 depletion. Importantly, the knockdown of CDK9 also reduced the 
ubiquitination of PCNA and H2B which both depend on Rad6 activity.  
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The ubiquitination of PCNA is an important component in the Fanconi 
anemia network which is essential for the repair of interstrand DNA crosslinks 
(Geng et al, 2010). Previously the increased sensitivity of Fanconi anemia cells to 
DNA-crosslinking drugs like mitomycin C (MMC) was demonstrated (Geng et al, 
2010). Moreover, the combinatorial treatment with flavopiridol and MMC 
significantly increased the efficiency of apoptosis induction in breast cancer cells 
(Schwartz et al, 1997). Since CDK9 is strongly inhibited by flavopiridol we now 
provide a potential mechanistic model for the observed effects which may provide 
a rational basis for testing more specific CDK9 inhibitors in combination with 
interstrand crosslinkers.  
Very recently the importance of H2B ubiquitination in DNA damage repair 
was shown (Moyal et al, 2011; Nakamura et al, 2011). Although details are still to 
be clarified it is already obvious that H2Bub1 in the sites of DNA damage is 
absolutely crucial for proper repair process. The cumulative effect of DNA break-
inducing treatments and potent CDK9 inhibitor flavopiridol on promoting 
apoptosis in cancer cells has been known for a long time. Flavopiridol was able to 
induce apoptosis in colon carcinoma HCT116 cells treated with low concentrations 
of topoisomerase I inhibitor camptothecin (Motwani et al, 2001). Ovarian 
carcinoma cells exhibited increased radiosensitivity upon flavopiridol treatment 
(Raju et al, 2003). The deletion of the tumor suppressor p53 and overexpression of 
the antiapoptotic protein Bcl-2 could not impair the ability of flavopiridol to 
increase the effect of ionizing radiation (Hara et al, 2008). The radiosensitivity of 
xenographic mammary carcinoma, ovarian carcinoma, lymphoma and glioma in 
mice was improved by flavopiridol as well (Mason et al, 2004; Newcomb et al, 
2004). Different mechanisms of flavopiridol action were proposed starting from 
the cell cycle regulation to the modulation of PARP activity. Although some 
authors mentioned CDK9 as one of the relevant flavopiridol targets no clear 
connection to the chromatin modifications has been made so far.   
Taken together the radiosensitizing activity of CDK9 inhibitor flavopiridol, 
H2Bub1-dependent dsDNA breaks repair and our data connecting CDK9 and 
H2Bub1 provide a completely new, distinct mechanism of P-TEFb-mediated 
genome integrity control.  
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5.3 Stress-induced reduction of H2B ubiquitination 
5.3.1 H2Bub1 is strongly reduced by various treatments 
In the course of this study we have demonstrated an interesting 
phenomenon partly described previously. The ubiquitination of histone H2B is 
rapidly and strongly reduced upon various treatments such as chemotherapeutic 
drugs (doxorubicin, etoposide, camptothecin, cisplatin), µltraviolet irradiation, 
osmotic stress (sorbitol) and heat shock. Quite surprisingly ionizing irradiation did 
not affect H2Bub1 levels although causing significant DNA damage. Remarkably, 
the chemotherapeutic DNA-damaging drug doxorubicin decreased the H2Bub1 
only at concentrations at least 5 fold higher than needed for a strong DNA damage-
response induction. This finding looks, however, less surprising if taken into the 
context of recent research reporting that H2B ubiquitination is rather induced at the 
sites of DNA damage and needed for the proper repair (Moyal et al, 2011; 
Nakamura et al, 2011). This suggests the existence of another pathway regulating 
H2Bub1 under unfavorable conditions.  
Previous studies also reported strong reduction of H2B ubiquitination 
following the treatment with proteosome inhibitors, heat shock and inhibitors of 
transcription (Davie & Murphy, 1990). The model proposed by authors included 
the depletion of free monomeric ubiquitin due to the insufficient turnover of 
polyubiquitinated proteins in the cell. This explanation apparently does not fit the 
picture we observe since most treatments we apply do not cause the accumulation 
of polyubiquitinated proteins. Moreover, the reduction of H2Bub1 upon treatment 
can be rescued by pre-treatment with caffeine. Altogether this data suggests an 
actively regulated multiple factor-induced pathway of H2Bub1 reduction.  
The physiological role of this massive change of chromatin status is not 
clear yet. Yeast cells are known to rapidly shut off the transcription of almost all 
genes within the first 10 min after strong stress like osmotic stress (Miller et al, 
2011). The new wave of gene expression which starts after 15 min is already 
corrected in accordance with new conditions. We can speculate that similar 
reprogramming takes place in human cells as well. H2Bub1, being a transcription-
specific chromatin mark, would be expected to be rapidly removed. 
Another possible explanation of the observed effects may utilize the novel 
finding that H2Bub1 keeps the chromatin uncompacted. The dosages of treatments 
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needed to induce a quick loss of H2Bub1 are usually very high and are very likely 
to induce apoptosis. As we know, one of the apoptotic events is an ATP-dependent 
chromatin condensation (Kass et al, 1996). Thus, the rapid loss of H2B 
ubiquitination we observe might be one of early apoptotic events. 
5.3.2 JNK and nucleolar signaling are involved in reduction of H2Bub1 
Nucleoli are known to rapidly respond to a variety of stresses and, what is 
important for us, their function is tightly controlled by c-Jun N-terminal kinase 
(JNK) signaling. JNK has been shown to phosphorylate and inactivate TIF-IA, a 
specific RNAPI transcription factor. It in turn leads to the failed ribosomal 
biosynthesis and nucleoplasmic translocation of nucleolar proteins like NPM, L5, 
L11, ARF, etc. (Mayer et al, 2005). 
Further analysis of stress-induced H2Bub1 changes revealed a strong 
dependence of this chromatin modification on the activity of JNK. JNK is known 
to be activated by various environmental stresses (Minden & Karin, 1997). 
Pretreatment of cells with a specific JNK inhibitor partially rescued the effects of 
both UV and doxorubicin on H2Bub1. Importantly, both these treatments increase 
JNK activity. In opposite, the overexpression of activated JNK led to the reduction 
of the global H2Bub1 level. At the moment JNK seems to be the only known 
kinase whose activity downregulates H2B ubiquitination.  
Thus, the induction of nucleolar stress via a direct mechanism (e.g. 
actinomycin D) or indirect mechanisms involving JNK or rRNA processing (i.e. 
NPM or NCL knockdown) suggest an intimate connection between nucleolar 
integrity and the maintenance of H2Bub1. It was recently shown that MYBBP1A 
and MKI67IP proteins are released from nucleoli upon blocking their function by 
knocking down TIF-IA (Kuroda et al, 2011). The described function of these two 
proteins is acetylation of p53 in order to stabilize it and induce a p53-response 
which leads to either cell cycle arrest or apoptosis. However, all our experiments 
with H2Bub1-reducing treatments were done in the H1299 cell line, which is p53-
negative. The recent data obtained in our lab shows that MYBBP1A and MKI67IP 
are also RNF40 binding proteins. We also cannot exclude the possibility that 
MYBBP1A and MKI67IP not only interact with RNF40 but also inhibit it by 
acetylation. Nopp140, which is also normally localized in nucleoli, was also shown 
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to interact with RNF40 in our experiments. We thus propose an inhibition H2B 
ubiquitination by stress-released nucleolar components.  
 
5.3.3 Stress and DUB activity 
According to our data the loss of H2B ubiquitination happens very rapidly 
which is difficult to explain with inhibition of RNF40 alone. We hypothesized the 
activation of certain de-ubiquitinating enzymes (DUBs) as a mechanism of quick 
H2B deubiquitination. We were indeed able to demonstrate the increase of a 
deubiquitinating activity in cells treated with doxorubicin. This activity was 
completely abolished by adding DUB inhibitors such as IAA, NEM or NiCl2 
proving that it came from one of ubiquitin-specific proteases (USPs). Further 
analysis allowed us to conclude that USP22 was the enzyme which was at least 
partially responsible for the stress-induced deubiquitination. USP22 was already 
shown to deubiquitinate H2B in vitro (Zhao et al, 2008). Normally it is found as a 
component of Spt-Ada-Gcn5-Acetyltransferase (SAGA) complex and is involved 
in the deubiquitination of histone H2A and H2B. USP22 was also identified as a 
component of a so-called “death from cancer” signature, a specific gene expression 
profile containing several genes whose expression is associated with poor clinical 
prognosis of cancer patients (Glinsky et al, 2005). We also showed in vitro 
phosphorylation activity of JNK on USP22. Thus, this phosphorylation may 
potentially modify the affinity of the USP22 zinc-finger domain to certain 
interaction partners thereby changing its activity and specificity. For example, the 
USP22 deubiquitinating module (containing ATXN7L3 and ENY2) may be 
released from the core SAGA complex and function in a SAGA-independent 
manner. Consistent with this hypothesis, no effect of the core SAGA component 
GCN5 was observed on the stress-induced loss of H2Bub1 (data not shown). The 
knockdown of USP22 gave partial rescue of H2Bub1 level upon several stresses. It 
is quite possible that several USPs such as USP27 perform this function though. 
The above given information provides interesting possibilities for 
improving the efficiency of X-ray therapy of tumors. As we know from previous 
research the successful repair of double strand DNA breaks requires the deposition 
of ubiquitinated H2B into the region of damaged chromatin repair (Moyal et al, 
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2011; Nakamura et al, 2011). It is quite easy to imagine the impairment of the 
DNA repair process in case we were able to abolish the H2Bub1 in tumor tissues. 
 
5.4 The role of H2Bub1 in cancer biology 
The role of H2Bub1 in tumors biology is another interesting aspect. As we 
mentioned before the proteins involved in H2Bub1 level regulation are often mis-
expressed in cancers. It’s not easy now to explain the details of this regulation, but 
most probably H2Bub1 would be reduced in tumors. In support of this, a CpG 
island in the promoter of the RNF20 gene was shown to be highly methylated in 
human breast tumors in comparison to normal tissues (Shema et al, 2008). 
Moreover, changes in the expression or activity of USP22, RNF40 or UBE2A 
could also potentially be altered during tumorogenesis.  
One possible outcome of such a reduction might be an increase of 
metastatic activity. It is known that diffusion-based hypoxia in tumors promotes 
the spreading of metastasis (Chaudary & Hill, 2007). At the same time the activity 
of H2B E3 ubiquitin ligase RNF20 has been shown to reduce the migration 
potential of cancer cells (Shema et al, 2008). We can hypothesize that tumor cells 
which manage to inactivate H2B ubiquitinating system would gain an advantage of 
high motility in hypoxic conditions. Alternatively, hypoxic stress itself, like the 
other investigated stresses, might lead to a loss of ubiquitination, thereby 
increasing the cell’s propensity. 
Another possible role of H2Bub1 loss in tumor biology came out of the 
experiment in which we observed a strong reduction of γH2AX upon RNF40 
knockdown (data not shown). Some cancer cell lines with a high growth rate 
demonstrate quite a significant level of γH2AX in the absence of any DNA 
damage. This could be a result of so-called replication stress, which is caused by 
disruption of DNA replication forks during the S-phase of cell cycle. The cells 
with low levels of H2Bub1 might not recognize such events properly and keep 
growing at a higher rate meanwhile accumulating chromosomal aberrations, which 
is typical for cancer cells.  
 To shed some light on these and other problems further careful and 
extensive study of this process is required for the development of solid knowledge 
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of stress-induced H2B deubiquitination and the role of H2B monoubiquitination 
during tumorogenesis and metastasis. 
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